Next Article in Journal
Structural Basis for D3/D4-Selective Antagonism of Piperazinylalkyl Pyrazole/Isoxazole Analogs
Previous Article in Journal
Cerium Phosphate Nanoparticles: Synthesis, Characterization, Biocompatibility, Regenerative Potential, and Antioxidant Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Efficient Approaches to the Design of Six-Membered Polyazocyclic Compounds—Part 2: Nonaromatic Frameworks

by
Yuliya Yu. Titova
*,
Elena A. Gyrgenova
and
Andrey V. Ivanov
A.E. Favorsky Irkutsk Institute of Chemistry, The Siberian Branch of the Russian Academy of Sciences, Favorsky Str. 1, 664033 Irkutsk, Russia
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(19), 3911; https://doi.org/10.3390/molecules30193911 (registering DOI)
Submission received: 1 September 2025 / Revised: 25 September 2025 / Accepted: 26 September 2025 / Published: 28 September 2025
(This article belongs to the Section Organic Chemistry)

Abstract

This review summarizes and compares literature data on the main strategies for the synthesis of saturated and/or partially saturated analogs of six-membered polyazoaromatic heterocycles. With a few exceptions, this data was published within the last 15–20 years. These strategies include, first of all, hydrogenation, which can be carried out in a classical manner (i.e., in the presence of a catalyst and molecular hydrogen) or via hydrogen transfer techniques. Other approaches comprise saturation of aromatic frameworks, which can be achieved using compounds other than hydrogen, such as hydroboration and dearomatic binding, or the creation of saturated or partially saturated polyazo heterocycles through the coupling of two or more molecules. Each of the above strategies has certain advantages and serious shortcomings and limitations. Despite the apparent methodological difficulties, it is demonstrated that the described approaches can sometimes give impressive results, including the production of optically pure products under relatively mild conditions.

1. Introduction

Saturated or partially saturated analogs of polyazoaromatic heterocycles are important structural motifs of biologically active molecules and/or pharmaceuticals (Figure 1) [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15]. For example, Luotonin A exhibits cytotoxicity against the murine leukemia cell line P-388, as well as possesses antiviral and fungicidal activities [16]. Asperlicin D has antagonistic activity against cholecystokinin [17]; 1-(4-aminobenzyl)-3-(3,5-dimethylbenzyl)-1,3,5-triazine-2,4-dione is active against human immunodeficiency virus (anti-HIV-1) [18]; 2,6-dibutyltetrahydro-2,3a,4a,6,7a,8a-hexaazacyclopenta[def]-fluorene-4-thioxo-8-one and its analogs have antimicrobial activities [19] etc.
Although hydrogenation or dearomatization of polyazocyclic compounds is considered to be one of the most convenient methods for the synthesis of their saturated analogs, this strategy is rather difficult to implement [20]. This phenomenon can be attributed to a number of factors, including the high aromaticity and stability of cyclic π-electronic systems, as well as the presence of several strong coordinating nitrogen atoms, both in the starting compounds and the molecules of possible products, which contribute to the catalyst poisoning [21]. Therefore, despite over a century of research in this area, the development of methodologies that can selectively convert N-heteroarene rings into the corresponding saturated or partially saturated cyclic N-containing skeletons under mild conditions remains an extremely challenging and urgent task [22].
On the other hand, disruption of the cyclic π-system of a heteroaromatic compound usually results in the formation of at least one sp3-hybridized carbon atom that can become a chiral center. This adds diversity and complexity to the now chiral-saturated or partially saturated heterocyclic skeleton, enabling the creation of structures that closely resemble natural compounds. However, most current strategies for saturation of different heterocycles are based on heteroaromatic compounds with only one heteroatom [22,23,24,25].
A comprehensive review of the literature indicates that there are three main methodologies for the preparation of saturated polyazocyclic compounds (see Figure 2). The first one is the hydrogenation of the corresponding unsaturated analogs, which is accomplished through the addition of one or more hydrogen molecules. Moreover, the hydrogenation of frameworks containing two nitrogen atoms can be achieved in two ways: (1) classical hydrogenation in the presence of molecular hydrogen and a catalyst, whereby often one nitrogen atom is preliminarily blocked by alkylation and the more basic secondary nitrogen atom is transformed into a salt by the action of an acid obtained in situ. The chiral version of these techniques is realized in the presence of special ligands, whose physicochemical properties allow them to retain chirality under harsh conditions (moderate to high pressures, a wide temperature range, and long reaction times) [23,26,27,28,29,30]; (2) so-called transfer hydrogenation, where the hydrogen source is a substance that is transformed during hydrogenation into a new molecule, which is ideally unable to react with either the original substrate or the target product(s). This method does not require a change in pressure; however, it is imperative to exercise caution when selecting the composition of catalytic systems [31]. To date, no examples of hydrogenation of molecules containing triazine and tetrazine fragments using these methods have been found.
The second methodology is saturation, i.e., the addition of one or more molecules to the N-arene ring. The most well-developed examples described in the literature are hydroboration processes [32,33].
The third methodology involves the construction of polyazocyclic compounds, which is carried out, e.g., through the formation of the corresponding saturated N-heterocyclic framework via the binding of two or more molecules and ring expansion reactions, as well as intramolecular and intermolecular cyclizations [10,34,35,36,37] (see Figure 2). This process can be realized under a wide range of conditions, which are largely determined by the nature of the target products.
In spite of the fact that some attention has been paid to the synthesis of saturated polyazocyclic frameworks, it is evident that this field of research is still in its nascent stage. Moreover, the question of the scientific selection of an effective methodology for a particular model substrate has not yet been addressed. It should be underlined that the development of new techniques is contingent upon a comprehensive understanding of the scientific literature, particularly that which has been published within the last two decades. This review will therefore summarize literature data from the last twenty years describing various experimental protocols for the synthesis of saturated and/or partially saturated nonaromatic polyazocyclic frameworks, using pyridazine, pyrimidine, pyrazine, and tri- and tetra-azo fragments as examples. The information is presented in accordance with the increasing number of nitrogen atoms in the six-membered ring. First, hydrogenation techniques will be surveyed, followed by a discussion of saturation, predominantly hydroboration methods, and finally, dearomatization possibilities.

2. Saturation of the Six-Membered Polyazo Heterocycles

2.1. Methodology of Classical Hydrogenation

2.1.1. Pyridazine Moiety

Du et al. [38] reported the first transition or rare-earth metal-free hydrogenation of 3,6-diarylpyridazines 1 using B(C6F5)3 as a catalyst (Scheme 1a). Various derivatives of 1,4,5,6-tetrahydropyridazine 2 were obtained in 77–95% yields. A tentative reaction mechanism was proposed (Scheme 1b).
It was suggested that H2 is cleaved in the presence of B(C6F5)3 and 1 to afford compound A (Scheme 1b). The second H2 molecule is cleaved in the presence of B(C6F5)3 and A, delivering product 2. It was noted that the reason for the hydrogenation stopping at this stage is not yet clear.
Although the authors [38] claim to have successfully realized their method for the first time using commercially available B(C6F5)3 as a catalyst, the high price of B(C6F5)3 and the relatively elevated hydrogen pressure required (50 bar) are significant drawbacks of this work.

2.1.2. Pyrimidine Moiety

The asymmetric hydrogenation of pyrimidines 3 with high enantioselectivity (up to 99% ee) in the presence of an iridium catalyst consisting of [IrCl(cod)]2, a ferrocene-containing chiral diphosphine ligand 4 (Josiphos), iodine, and Yb(OTf)3 (where cod = 1,5-cyclooctadiene) was reported in [39] (see Scheme 2). It was shown that ytterbium triflate is crucial for both achieving high enantioselectivity and activating the heteroarene substrate.
In 2023, Hao et al. [40] implemented the rhodium-catalyzed reductive dearomatization of 7-substituted pyrazolo[1,5-α]pyrimidines (6) to chiral 4,5,6,7-tetrahydropyrazolo[1,5-α]pyrimidines (9) with excellent enantioselectivity (ee up to 98%) (Scheme 3a). A plausible reaction mechanism was proposed (Scheme 3b).
Based on the results of DFT calculations and experiments involving deuterium, it was postulated [40] that rhodium complex A (Scheme 3b) first undergoes oxidative addition with H2 to form compound B. Then, substrate 6 coordinates with B to give compound C, followed by hydride transfer to compound D, accompanied by the formation of intermediate compound E, and complex A is regenerated by reductive elimination of compound D. Finally, intermediate compound E can further undergo hydrogenation to afford the final product 9.
Zhou et al. [41] described an efficient iridium-catalyzed asymmetric hydrogenation of pyrazolo[1,5-α]pyrimidines 10 (ee up to 99%) (Scheme 4a). Trichloroisocyanuric acid, Cu(OTf)2, Sc(OTf)3, Yb(OTf)3, and AgOTf were employed as activating agents (12). The synthesis was carried out on a decagram scale. The potential and promise of this approach were highlighted. In addition, a possible reaction mechanism was presented (Scheme 4b).
The process described in Scheme 4b begins with 1,2-hydride addition to form a semihydrogenated olefin intermediate A. This reaction is reversible since A can be dehydrogenated in the presence of an iridium catalyst. The C6–C7 double bond of A is then incorporated into the Ir–H bond to form B. Next, β-hydride elimination affords an enamine intermediate C, which can be isolated. Then, acid-catalyzed isomerization of the enamine/imine produces an iminium-containing intermediate D, followed by hydrogenation to give the desired product 12.
A highly enantioselective method for the complete hydrogenation of pyrimidinium salts 14 using the Ir/(S,S)-f-Binaphane complex as a catalyst was disclosed in [42]. This approach provides easy access to a variety of fully saturated chiral hexahydropyrimidines 16, which are ubiquitous in numerous bioactive molecules. The reaction proceeds under mild conditions to afford the products in high yields and enantioselectivity (Scheme 5). It was noted that the implementation of this process in continuous flow mode further extended its practical relevance.
Interestingly, in addition to the possibility of carrying out the transformations described in Scheme 5 at −20 °C, the authors presented data on performing this reaction in a flow at 50–80 °C, with R1 = Ph. The optimal ligand was selected at room temperature. Furthermore, a gram-scale experiment revealed that the reaction time was 168 h, rather than 72 h, as indicated in Scheme 5.
An efficient method for palladium-catalyzed asymmetric hydrogenation of 2-hydroxypyrimidines 17 with ee up to 99% was elaborated in [43] (Scheme 6). Unfortunately, this approach requires not only high hydrogen pressure but also a rather complex multicomponent catalytic system, which can be considered a notable drawback.
Despite the possibility of obtaining compounds that cannot be obtained by other means, all the methods presented in this section have a significant drawback: the need to work at high hydrogen pressure (over 50 bar). This requires specialized equipment and adherence to strict safety regulations.

2.1.3. Pyrazine Moiety

Zhou et al. [44] proposed a strategy in which one nitrogen of the product was blocked by alkylation, and the more basic secondary nitrogen of piperazine formed a salt with the acid obtained in situ (Scheme 7). The reaction was accomplished in the presence of catalytic systems based on the iridium complex [Ir(cod)Cl]2 and chiral ligands, such as (tBu, Sp)-Josiphos (20) (Scheme 7a) and (R)-Segphos (11) (Scheme 7b).
It was shown that a highly enantioselective iridium-catalyzed hydrogenation of pyrrolo[1,2-α]pyrazinium salts 24 provided a direct access to chiral derivatives of 1,2,3,4-tetrahydropyrrolo[1,2-α]pyrazine 26 with enantioselectivity up to 95% [26] (Scheme 8). A key feature of the reaction is the addition of cesium carbonate, which increases conversion and prevents racemization of the products (17 substrates were used in the work).
A method for the asymmetric catalytic hydrogenation of pyrazines 27 in the presence of iridium complexes 28, dioxane, and Brønsted acid composition was reported in [29] (Scheme 9). The reaction proceeded with acceptable selectivity to deliver the products 29 in moderate to good yields. It should be noted that the authors optimized the conditions of the studied process in the presence of seven Ir complexes (28) (Scheme 9) and thirteen additive compositions, namely, lutidine·HCl, lutidine·HBr, lutidine·HI, lutidine·C6F5COOH, lutidine·TsOH, 2,6-(t-Bu)2pyridine·HBr, aniline·HBr, p-MeO-aniline·HBr, p-CF3-aniline·HBr, N-methylaniline·HBr, N,N-dimethylaniline·HBr, N,N-dimethylaniline·HCl, and N,N-dimethylaniline·HI. The combination of 28j and DMA·HBr was found to be optimal.
The possibility of pyrazine ring saturation was also shown in the study by the authors of [45], which was devoted to the efficient synthesis of chiral polyheterocyclic compounds with several nitrogen atoms in the presence of an iridium complex. It is noteworthy that without additives, a number of chiral 2,5-disubstituted 5,6-dihydropyrrolo[1,2-α][1,2,4]triazolo[5,1-c]pyrazines 31 were obtained in high yields (86–98%), and excellent enantioselectivity was achieved (up to >99% ee) (Scheme 10).
The asymmetric hydrogenation of pyrazine derivatives in the presence of iridium catalysts was described by Stoltz et al. [23]. Also, for this purpose, ruthenium [46] and palladium [47,48] catalysts were employed. All the above versions of hydrogenation were implemented in the presence of molecular hydrogen, and under pressure of 20–80 bar, depending on the catalyst and the nature of the substrate. In addition, the reaction required a long time, which can be considered a significant disadvantage of the process.

2.2. Other Methodology of the Saturation

2.2.1. Pyrimidine Moiety

The first anion-binding organocatalyzed enantioselective Reissert-type dearomatization of pyrimidines 32 was documented in [31] (Scheme 11). Tetrakistriazole-based H-bond donor catalysts (TrocCl, CbzCl, and MeOCOCl) were more effective than other known hydrogen-bond donors, providing the corresponding products in high regioselectivities and up to 96 (34):4 (35) er. The formation of possible isomer 36 was not observed.
Unfortunately, the reaction requires a rather complex multicomponent catalytic system, which can be considered a significant disadvantage. In addition, during the second stage of implementation of the methodology, the temperature must be lowered to −78 °C.
A method for the catalytic nucleophilic dearomatization of 2-hydroxypyrimidines 37 using ZrCl4 as a catalyst and dialkyl phosphite 38 as a nucleophile was developed [37]. The reaction was carried out under mild conditions (Scheme 12).
The method presented in [37] is simple and does not require the use of expensive reagents other than zirconium salt. It can be performed at room temperature, but requires a longer reaction time.

2.2.2. Pyrazine Moiety

Crabtree et al. [48] developed an interesting method for the regioselective reduction of N-heteroaromatic compounds. The method comprises the combination of hydrosilylation using 3 mol% [Rh(cod)(PPh3)2]PF6 and 4 eq. silane in toluene at room temperature, with subsequent hydrogenation with hydrogen transfer using 1 mol% [Ir(cod)(NHC)PPh3]BF4 in isopropanol with 0.5 eq. K2CO3 at 82 °C. According to the authors of [48], 1.00 mmol of pyrazine was fully hydrogenated within 24 h. Unfortunately, the authors did not provide data on the possibility of obtaining optically pure products using this method.
The authors of [49] demonstrated that the dearomatization of N-heteroarenes, including those containing a pyrazine fragment 40, can be achieved using a LiHBEt3–SiPhH3-derived composition; the yield of the target products 41 reached 90% (Scheme 13). A plausible reaction mechanism was described based on DFT calculations (without providing a scheme).
Liu et al. [50] accomplished the regioselective hydroboration of the pyrazine fragment 42 with pinacolborane 43 (HBpin) in the presence of commercially available potassium-based catalysts to furnish 1,4-regioselective hydroborated products 44 in quantitative yields (Scheme 14). The pyrimidine ring can also undergo hydroboration in this manner to give the target product in 96% yield.
The saturation of the pyrazine ring occurs in a similar way in the presence of such systems as I2-HBpin [51] and PhSiH3-HBpin [52]. In addition, it was shown that the PhSiH3-HBpin composition was efficient in the saturation of the pyrimidine.
A general approach to the dearomatizing hydroboration of N-heterocycles (including those with a pyrazine ring) using 31 high-performance catalytic systems based on d- and f-element complexes was outlined in a remarkable paper [53]. The optimal conditions for each catalytic composition, as well as the possible conversion mechanisms, were discussed in detail. It was emphasized that significant progress has been made in recent years within the domain of research concerning the hydroboration of N-heteroaromatic compounds using rare-earth catalysts.
An efficient method for electrocatalytic hydrogenation of pyrazine to piperazine was disclosed in [54]. The reaction occurred at ambient temperature and pressure in the presence of an anion-exchange membrane electrolyzer equipped with a Rh/C cathode that also acted as a catalyst.
A method for the direct reduction of the pyrazine ring 45 was developed [55]. It is noteworthy that this method is based on the Birch-type photoreduction catalysis under blue light irradiation, when diisopropylethylamine (1 eq.) was employed as the sacrificial electron donor, and 1 mol% Ir[dF(CF3)ppy]2-(dtbpy)PF6 46 (where dF(CF3)ppy = 2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine and dtbpy = 4,4′-di-tert-butyl-2,2′-bipyridine) was used as a photocatalyst, with DMFA (1 mL) used as a solvent. The reduction process was carried out at room temperature in air for 2 h (Scheme 15a). A general tentative mechanistic scheme was given (Scheme 15b). It was noted that pyridazine rings can also be reduced by this method, but the yield was half that obtained by reducing the corresponding pyrazine analogs.
The authors of [55] suggested that, when photoexcited by visible light 46, the lowest triplet excited state, *IrIII, sensitizes the formation of the triplet state of the heteroarene* A. Consequently, one blue photon (455 nm of 2.72 eV) is used for the energy transfer process (Dexter energy transfer). In parallel, a second blue photon, excited by *IrIII, is quenched by DIPEA to form the IrII complex and the radical cation of DIPEA D. The excited heteroarene* A is reduced by the IrII complex to form heteroarene•− B, which extracts a hydrogen atom from the radical cation of DIPEA D, producing the heteroarene carbanion C. Finally, protonation from MeNH3Cl or the iminium ion of DIPEA yields the reduced product 47. The evidence obtained by the authors of [55] using UV–visible and EPR spectroscopy methods partly confirms their conclusions.

2.2.3. Triazine Moiety

The method for the saturation of the 1,3,5-triazine 48 ring through the hydroboration reaction under mild conditions in the presence of thorium complex 50 (Scheme 16) was described in [33].

3. Construction of the Six-Membered Nonaromatic Polyazole Cores

This section discusses approaches to the construction of polyazocyclic compounds with fully or partially saturated N-containing fragments, that is, containing one double bond or containing no multiple bonds at all. The binding of several molecules that results in the formation of six-membered polyazocyclic compounds containing two double bonds, with (as a rule) still-retained aromaticity, was surveyed in the first part of this review.

3.1. Diazine Compounds

3.1.1. Pyridazine Moiety

The recyclization method can be used to obtain pyridazines by either contracting, reducing the ring (diazepinone [56]), or expanding (dimethylfuran [57]). Scheme 17 shows the recyclization of 5-hydroxy-Δ1-pyrrolines 52 with hydrazines 53 to give pyridazines 54.

3.1.2. Pyrimidine Moiety

Guo’s group developed a Cu-catalytic approach to the preparation of pyrazolo[1,5-c]quinazolines 58 from substituted pyrazoles 55 (Scheme 18) [58].
During the chemical transformation shown in Scheme 18, in the resulting products 58, one of the nitrogen atoms of the nonaromatic six-membered ring also belongs to the adjacent five-membered aromatic cycle. As this does not formally contradict the main purpose of this review, the scheme was included.
The [2+2+2]-cycloaddition reaction of 1,3,5-triazinane 59 with diethyl ester of acetylenedicarboxylic acid 60 was studied in [59] (Scheme 19a). The process proceeded under mild conditions, without a catalyst to deliver the products 61 in moderate to excellent yields (up to 99%). A tentative reaction mechanism was rationalized (Scheme 19b).
Based on the data of high-resolution mass spectrometry (HRMS), the authors of [59] suggested that the nucleophilic addition of in situ-obtained formalin to electron-deficient alkynes 60 generates Huisgen’s 1,4-dipoles A ([M]+ = 276.1230), which interact with another formalin, forming an intermediate compound B ([M]+ = 381.1809). Then, intramolecular ring closure leads to the target product 61.
Polysubstituted tetrahydropyrimidines 64 can be synthesized by the protocol published in [60]. The facile, straightforward, and environmentally benign reaction proceeds via a formal catalyst-free [3+3]-cycloaddition of imines 62 to 1,3,5-triazines 63 (Scheme 20a). The highest yields were achieved in toluene at 60 °C. A plausible reaction mechanism was presented (Scheme 20b). In addition, it was shown that the process can be scaled up on a gram level.
The authors of [60] suggested that dissolution of 1,3,5-triazine 63 in a solvent would result in the formation of formalimine A, which could further decompose into 4-methoxyaniline A1 and formaldehyde A2 due to the presence of a small amount of water in the solvent. Imine 62 could isomerize into enamine B in the reaction system. The whole process could be caused by a formal azaene-type reaction between enamine B and formalimine A, affording active intermediates β-aminoimine C or 1,3-diamine D. These intermediates then react with the in situ-formed formaldehyde to form the condensation product of tetrahydropyrimidine 64 and release one molecule of water into the reaction system. Unfortunately, no detailed description of the role of water was presented in [60], nor was there any evidence of formaldehyde formation.
The 1,2,3,4-tetrahydropyrimidines 67 bearing a partially saturated aromatic ring were also prepared in [61] (Scheme 21). The substrate scope of this reaction was evaluated using more than 37 substrates. Some of the products showed potential antitumor activity. It was demonstrated that the formation of the tetrahydropyrimidines 67 is a temperature-controlled process that requires no special additives. The utilization of N-methylpyrrolidone in the reaction is a notable benefit of this protocol.
The tetrahydropyrimidines 70 were obtained in moderate to good yields using the Sc(OTf)3 complex as a catalyst (Scheme 22a) under relatively mild conditions. A possible reaction mechanism was provided in [62] (Scheme 22b).
According to Scheme 22b, 1,3,5-triazinane 69 decomposes under the action of the Lewis acid Sc(OTf)3 to form N-phenylmethanimine A, while enaminone G is transformed to its isomeric form B. Michael addition of the latter to imine A forms iminium C, and a subsequent intramolecular O-Mannich reaction generates oxonium ion D if R is an aryl group. Oxonium D undergoes proton transfer to intermediate E and then, after elimination of dimethylamine, delivers the desired product 70. Alternatively, the NH group in intermediate C can preferentially attack the alkylimine released from 1,3,5-trialkyl-1,3,5-triazinane to form intermediate F, which prevents the hydroxyl group from attacking its C=N bond to give the chromone skeleton. Finally, the nitrogen ion in intermediate F attacks its C=N bond to complete the intramolecular ring closure, producing the desired N,N-dialkyltetrahydropyrimidine 68 and releasing dimethylamine. Unfortunately, the authors of [62] did not provide any physicochemical evidence of this mechanism.
Li et al. [63] synthesized tetrahydropyrimidine derivatives 73 in good to excellent yields via rhodium(II) complex-promoted [4+2]-annelation of 1-sulfonyl-1,2,3-triazoles 71 with hexahydro-1,3,5-triazines 72 under relatively mild conditions (Scheme 23a). A tentative reaction mechanism was described (Scheme 23b).
According to Scheme 23b, α-iminorhodium carbene A, which can be readily prepared from 1-sulfonyl-1,2,3-triazole 71 in the presence of a rhodium(II) catalyst, can be converted to the α,β-unsaturated imine C via a 1,2-ether migration process. In route a, the nitrogen of hexahydro-1,3,5-triazine 72 attacks intermediate C. Subsequent rapid cleavage of the C–N bond and the release of formadimin D leads to intermediate H, and then 1,2,3,4-tetrahydropyrimidine 73 can be obtained via the intramolecular cyclization. Meanwhile, at a high temperature, an equilibrium between hexahydro-1,3,5-triazine 72 and formadimin D is observed. Route b involves a stepwise [4+2]-annulation between C and formadimin D, starting from an aza-Michael reaction. In route c, a concerted mechanism can also explain the formation of the final product 73. Based on the electronic influence of the aromatic ring on triazines and the result of the reaction of triazole with imine, the authors of [63] considered route c as a possible exception. And in this case, the proposed scheme of the mechanism was not confirmed by any evidence obtained through physical and chemical research.
The assemblies of 1,2,3,4-tetrahydropyrimidines assisted by microwave radiation or ultrasound were documented. For example, it was reported [64] that 5-phosphoryl-1,2,3,4-tetrahydropyrimidines 76 were synthesized under microwave irradiation conditions (Scheme 24). The reaction represents a sequence of 1,3,5-triazinane 75 fragmentation and tandem nucleophilic addition of the obtained formaldimines and phosphoryl diazomethanes 74, followed by N,N-acetalization.
Furthermore, Grabowiecka et al. [65] developed an ultrasound-promoted method for the synthesis of dihydropyrimidines 78 (Scheme 25) with good to excellent yields.
Tetrahydropyrimidines 82 were prepared [66] under mild conditions via [2+1+3]-cycloaddition using aryl-substituted 1,3,5-triazinanes 80 (Scheme 26a) as three-atom synthons. A possible reaction mechanism was proposed (Scheme 26b).
According to the data obtained in [66], first, 1,3,5-triazinane 80 decomposes to the corresponding formaldimine A. Enamines B are obtained by hydroamination of amines 79 with alkyne ethers 81. Then B undergoes nucleophilic attack by formaldimines A to form the intermediate product C. In the synthesis of tetrahydropyrimidines (tetrahydropyrimidine formation pathway), C attacks another formaldimine A to give the intermediate product D. After hydrolysis, intramolecular cyclization of E affords product 82 (path 1). If R1 is a nitro-substituted group, 82-SP is produced by nucleophilic attack of a secondary amine and the eliminated nitroaniline (path 2). In the synthesis of dihydropyrrolidones (dihydropyrrolidone formation pathway), the nucleophilicity of the secondary amine C is enhanced by the attached alkyl group, which facilitates intramolecular addition to form G. The final product H is obtained by elimination of the alcohol.
Two synthetic protocols were reported for the preparation of chromeno[2,3-d]pyrimidin-5-ones using 1,3,5-triazinane as an N-containing building block via different reaction modes [67]. In the first case, the target product containing a partially saturated pyrimidine moiety 84 was obtained in the presence of an In(OTf)3 catalyst. The second protocol afforded the target product bearing an entirely saturated pyrimidine moiety 85 in 63–98% yield (Scheme 27a). A possible reaction mechanism was presented (Scheme 27b).
According to the data of [67], 1,3,5-triazinane under catalytic conditions in the presence of In(OTf)3 can be easily decomposed into three units of formaldehyde, which then react with trace amounts of water in a solvent to form amine and formaldehyde (Scheme 27(b1)). Notably, water will be regenerated from the subsequent condensation reaction, with the release of formaldehyde and amine. To obtain 84, In(OTf)3 catalyzes the formation of imine and subsequent Michael addition of formaldehyde to the α,β-unsaturated imine moiety, and then the pyrimidine ring is closed by an N-Mannich reaction (Scheme 27(b2)), while 2-amino-4H-chromen-4-one can directly attack 1,3,5-triazinane to give the aminomethylation product, and the remaining 1,3,5-triazinane is cleaved to formaldehyde (Scheme 27(b4)). The resulting formaldehyde can yield formaldehyde via hydrolysis for the subsequent condensation reaction. The resulting intermediate then undergoes imine–enamine tautomerism/imine formation, followed by an intramolecular N-Mannich reaction to give compound 85 (Scheme 27(b3)).
The first example of an inverse-electron-demand [4+2]-cycloaddition of 1,3,5-triazinanes 87 (Scheme 28) was reported in [68]. The reaction occurred in mild conditions in the presence of bases such as Na2CO3, K2CO3, Cs2CO3, KOH, and NaOH, with Na2CO3 being the most efficient.
Sun et al. developed [69] a method for the asymmetric formal [4+2]-cycloaddition of copper–allenylidene to hexahydro-1,3,5-triazines 90 to produce chiral tetrahydroquinazolines 92 in moderate to good yields (up to 88%) and with high enantioselectivity (ee 98%) (Scheme 29a). A plausible reaction mechanism was proposed, a possible mechanism is described, and the prospects of the method developed were outlined (Scheme 29b).
Remarkably, in the asymmetric cycloaddition described by Scheme 29b, the reaction yields two amphiphilic dipolar intermediates generated in situ: copper complexes with allenidine and formyl imine. Copper with allenidine is captured by formaldimine, followed by cyclization, which gives a chiral product.
The synthesis of 1,2,3,4-tetrahydroquinazolines 95 from α-azidocarboxylic acid 93 and 2-(aminomethyl)aniline 94 was accomplished in [70] (Scheme 30). The transformation was carried out in the presence of the ruthenium complex [CpRu(CO)2]2 under visible light and at room temperature to give the target products in almost quantitative yields.
A strategy for the preparation of hexahydropyrimidines (25 examples) via the cycloaddition of 1,3,5-triazinane to methylene-containing compounds was published in [71] (Scheme 31a). It was found that the reaction took place under mild conditions for 2 h to afford the products in up to a 99% yield. It was shown that this method can be scaled up to produce hexahydropyrimidines in gram quantities. A possible reaction mechanism was rationalized (Scheme 31b).
According to Scheme 31b, benzylimine A is formed from 97, which is then hydrolyzed to give aniline and formaldehyde in the presence of traces of water. In path a, B sequentially reacts with benzylimine A to give intermediates D and F, respectively. In path b, C is formed by the condensation of B with formaldehyde. C then undergoes a Michael addition reaction with aniline to generate the key intermediate D, which is further trapped by benzylimine A, delivering E. Finally, product G is obtained by cycloaddition of E/F and in situ-generated formaldehyde. It is noteworthy that the possible key intermediates C, D, E, and F were detected by high-performance mass spectrometry: for C [M+H]+ = 231.1016, for D [M+H]+ = 324.1594, for E [M+H]+ = 429.2173, and for F [M+H]+ = 429.2173.
A methodology for the preparation of hydropyrimidines by altering the position of the amino fragments was presented in [72,73]. The reactions were performed without catalysts and special additives. It was shown that two reaction directions are possible, in which either five atoms (i.e., C-N-C-N-C) or three atoms (i.e., C-N-C) of 1,3,5-triazine 99 can be sequentially introduced into annulation products (Scheme 32a). Possible mechanisms of these transformations were considered (Scheme 32b,c).
According to the data presented in [72], formaldimine could be obtained in situ from 1,3,5-triazinane, which is in equilibrium with formaldimine in the reaction system (Scheme 32b). Formaldehyde can be formed through the hydrolysis of formaldimine with traces of water, as reported in the works of previous authors. Then, 2-sulfonyliminoindoline reacts twice with the obtained formaldimin, introducing two aminomethyl groups at its 3-position, giving C. Subsequently, any of the obtained amino groups is condensed with formaldehyde, giving an iminium (e.g., D), which undergoes intramolecular N-Mannich annulation, to furnish pyrimidine-spiro-fused indolines 100b (equation C-N-C-N-C). Condensed indoles and their analogs 101 are formed along the pathway when the activated amino group is in the 3-position of benzoheterocycles (equation C-N-C).
On the other hand, another mechanism exists for the formation of derivative 100 (100a) [73] (see Scheme 32c). According to this mechanism, indoline-derived azadienes can rapidly react with formaldimines to form intermediate E, which then transforms into intermediate F. A ring closure reaction then occurs to produce the ten-membered cyclic intermediate G. Further, a ring contraction reaction takes place through the elimination of one benzaldehyde molecule from intermediate G to give a new eight-membered cyclic intermediate H. The latter undergoes another ring contraction reaction to afford formally [1+5]-annulated indoline-spiro-hexahydropyrimidine products via the subsequent protonation.
The cascade reaction of various Gewald aminothiophenes 102, 2-hydroxy-4-oxobut-2-enic acid 103, and cyanoacetic acid derivatives allowed the direct synthesis of various 1-(2-oxoethylidene)-2-oxothieno[3,2-e]pyrrolo[1,2-α]pyrimidines 104 (Scheme 33) [74].
Polyfunctionalized pyrrolo[2,3-d]pyrimidine derivatives 108 were synthesized in high yields [75] via a one-pot three-component reaction of arylglyoxal 105, 6-amino-1,3-dimethyluracil 107, and barbituric acid derivatives 106 (Scheme 34).

3.1.3. Pyrazine Moiety

In 2022, Jia et al. [76] reported highly interesting dearomatized [3+2] umpolung-annulation of a variety of o-halogenphenyl-substituted N-heteroarenes 109, including electron-deficient pyridines with alkynes 110 (Scheme 35). It was underlined that this strategy provided an efficient approach to a large number of chiral N-heterocyclic compounds 112 containing a spiro-quaternary stereocenter in moderate to good yields and with high enantioselectivity. The method tolerates both internal and terminal alkynes. A possible reaction mechanism was proposed.
It was revealed that a ruthenium-catalyzed annulative transfer hydrogenation strategy provided direct access to tetrahydrocondensed pyrazine derivatives from N-heteroaryldiamines 113 and vicinal diols 114 [77] (Scheme 36). The only by-product of this process was water.
Chang et al. [78] demonstrated the possibility of saturation of pyrazine (117–119) rings in the presence of alkoxide catalyst KO-t-Bu (Scheme 37a). A possible mechanism of this process was discussed (Scheme 37b).
Scheme 37b was proposed [78] based on experimental observations. It is suggested that 1,4-hydroboration of pyridines is realized via a KOt-Bu-promoted catalytic pathway. Initially, KOt-Bu reacts with HBpin (in excess) to rapidly establish a pre-equilibrium between several borohydride species, including KH2Bpin, KOt-Bu·HBpin, KOt-Bu·BH3, and KBH4. The in situ-formed pyridine-BH3 adduct undergoes nucleophilic hydride attack by the borohydride species to form 1,4-dihydropyridylborohydride (A), which is the major residual species. Hydride transfer from A to HBpin is proposed to occur slowly, reducing the borohydrides to release 1,4-dihydropyridylborane, presumably in the dimeric form (B2). Finally, monomeric B reacts with HBpin to give the product N-Bpin-1,4-dihydropyridine, releasing BH3, presumably via α-linkage metathesis.
In 2024, an enantioselective dearomatization of pyrazine 123 with terminal alkynes 124 in the presence of a copper complex (Scheme 38) using chloroformate as an activating reagent and (R)-StackPhos 125 as a chiral ligand was disclosed [35].
This method enables the synthesis of 2,3-disubstituted tetrahydropyrazines as a single diastereomer with high enantiomeric excess. These products can also be further converted into chiral C-substituted piperazines and C1-asymmetric 1,2-diamines. Mechanistic studies showed that the non-innocent role of the chloride ion can prevent the alkynylation of the second iminium, thus creating conditions for subsequent functionalization.
Moradi et al. demonstrated that sulfamic acid reacted efficiently with β-nitrostyrenes 127, ethylenediamine 128, and dimethylacetylenedicarboxylate 129 in a one-pot manner to generate pyrrolo[1,2-a]pyrazines 130 in good yields (Scheme 39) [79].
The main drawback of the methods described in this section is that they are multicomponent.

3.2. Triazine Compounds

3.2.1. 1,2,3-Triazines

H. Wippert et al. reported the five-step synthesis of compounds 132. The final step involved the cleavage of the triazene amide link from 131, followed by cyclization to pyrazolo[3,4-d][1,2,3]triazine compounds 132 (Scheme 40) [80].
Pyrrolo[1,2-c][1,2,3]triazines are a class of heterocycles that have received only limited attention from researchers. In 2014, two coauthors of this paper synthesized pyrido [3′,2′:4,5]pyrrolo[1,2-c][1,2,3]benzotriazines 134 by intramolecular cyclization of diazonium intermediates 133 (Scheme 41) [81]. The synthesis of pyrrolo[1,2-c][1,2,3]benzotriazines from 2-(1H-indol-2-yl)aniline was also disclosed [82].
In Scheme 41 (as in Scheme 18), one of the nitrogen atoms of the six-membered nonaromatic ring also belongs to the conjugated five-membered cycle. However, this fact does not formally contradict the main purpose of this review, which is why Scheme 41 was also included.

3.2.2. 1,2,4-Triazines

The authors of [83] demonstrated for the first time that the C-H bond can be activated using the [RhCp*(CH3CN)3](SbF6)2 complex to produce pyrazolidinone-condensed benzotriazines 137 (Scheme 42a). It was noted that this methodology enabled the preparation of valuable products in high yields from readily available substrates under redox-neutral conditions. A plausible mechanism of the reaction was considered. In addition, the process was scaled up (Scheme 42b).
According to Scheme 42b, the first step involves metallation of the C−H/N−H bond of model compound 135 with Rh(III) to form a five-membered rhodacycle A. Then, coordination of A with 136 produces intermediate B, which then undergoes migratory insertion with simultaneous ring opening of the oxadiazolone moiety and displacement of CO2, forming a six-membered rhodacycle C. Subsequent protodemetallation of intermediate C leads to the formation of the aminated intermediate D and regeneration of the active catalyst. In the next step of this cascade reaction, N-nucleophilic attack of the pyrazolidinone fragment on the in situ-established amidine fragment gives the intermediate compound E. Finally, ammonia is eliminated from E to deliver product 137. Unfortunately, as in many other works cited above, the authors of [83] proposed Scheme 42b based on the identification of the reaction products and analysis of literature data. No physicochemical studies of the process itself in situ were carried out.
Guo et al. [84] reported on the dearomatization via [4+2] annulation of N-heteroarenes 138 with azoalkenes 139 obtained in situ from α-halohydrazones 140 under mild conditions (Scheme 43). The application scope of this reaction was evaluated using scaled-up synthesis and product derivatization.
Dömling et al. [85] implemented microwave-assisted synthesis of the triazine derivatives 144 (Scheme 44).
The synthesis of trifluoromethylated 2,3,4,5-tetrahydro-1,2,4-triazines 147 in 81–97% via [2+1+3]-cycloaddition of trifluoroacetaldehyde N-sulfonylhydrazones 146 to hexahydro-1,3,5-triazines 145 was carried out in [86] (Scheme 45a). The reaction tolerated a wide range of substrates, including aryl, benzyl, and alkyl hexahydro-1,3,5-triazines. A plausible reaction mechanism was proposed (Scheme 45b). The process was scaled up to gram quantities.
According to Scheme 45b [86], the first step involves the dissolution of hexahydro-1,3,5-triazine 145 to form formalimines A, which then further decompose to the corresponding amine B and formaldehyde C due to the presence of a small amount of water in the solvent. Then, the in situ-formed formalimines A undergo a formal azaene-type reaction with N-sulfonylhydrazones to give intermediate D, which can be isomerized to E. Finally, intermediate E reacts with in situ-formed formaldehyde C to produce the final product 147. Scheme 45b is proposed based on the results of the reaction product analysis and literature sources.
Substituted triazines 150 were formed by the reaction of 1,6-diamino-2-oxo-4-aryl-1,2-dihydropyridine-3,5-dicarbonitriles 148 with oxalyl chloride 149 (Scheme 46) [87].

3.2.3. 1,3,5-Triazines

Treatment of 2-aminopyrroles 151 with aryl- or alkylisocyanates was demonstrated to form 3,7,8-trisubstituted pyrrolo[1,2-a][1,3,5]triazindiones 152 (Scheme 47) [88].
Pyrrolo[1,2-a][1,3,5]triazines 155 were obtained by a two-step reaction. Firstly, 2-amino-3-ethoxycarbonylpyrrole 154 was synthesized by the Hantzsch method via the condensation of amidine ester 153 and freshly distilled chloroacetaldehyde. Secondly, the reaction of pyrrole 154 with cyanate occurred (Scheme 48) [89].
Sabatini et al. [90] developed an elegant method for the synthesis of bis-1,3,5-triazinanes 158 (Scheme 49a). The reaction was carried out in the presence of samarium trichloride as a catalyst, water as a solvent, and glycoluril 157 and N,N-bis(methoxymethyl)-tert-butylhexanamine 156 as a substrate. It is interesting to note that the authors of [90] also synthesized compounds 158 on a 176 mmol scale to obtain 36 g of the product in several steps (see Scheme 49b), using paraformaldehyde and t-BuNH2 instead of the samarium catalyst.
Baranov et al. [19] also synthesized bis-1,3,5-triazinanes 160 according to (Scheme 50) via the condensation of 5-thioxohexahydroimidazo[4,5-d]imidazol-2(1H)-one 159 (1, monothioglycoluril) with paraformaldehyde and amines (11 examples).
A series of new fused aza heterocycles containing 1,3,5-triazinane fragments formed from glycoluril, 2,8-bis(hydroxymethyl)glycolurils, tetrakis(hydroxymethyl)glycoluril, and 1,4,5,8-tetraazadecalin were described in [91,92,93,94].
The synthesis of 2,7-bis-substituted 4,9(10)-dimethyl-2,3a,5a,7,8a,10a-hexaazaperhydropyrenes 164 and 165 (14 examples) via the intermolecular heterocyclization of N,N-bis(methoxymethyl)-N-alkylamines 163 with 2,6(7)-dimethyl-1,4,5,8-tetraazadecalines 161 and 162 under rather mild conditions in the presence of samarium catalyst was implemented in [95] (Scheme 51).
A research team developed a method for the cyclocondensation of arene(hetarene)amines 166 with formaldehyde 167 and 2,6-dimethyl-1,4,5,8-tetraazadecalin 168 in the presence of YbCl3·6H2O as a catalyst [96] (Scheme 52).
It should be underlined that the products described in [95,96] simultaneously contain piperazine and 1,3,5-triazinane moieties. In addition, all of the methods described by the authors are implemented in a one-pot manner under fairly mild conditions. The only significant drawback is the use of d- or f-element compounds as catalysts.

3.3. Tetrazine Compounds

3.3.1. 1,2,3,4-Tetrazine

In 2022, Renault et al. synthesized 1,2,3,4-tetrazine 171 (Scheme 53) by intramolecular cyclization of hydrazine 170 using CuI as a catalyst [97,98].

3.3.2. 1,2,3,5-Tetrazine

Diazoazoles 173 obtained via the diazotization reaction followed by the neutralization of the corresponding pyrroloamines 172 and their further interaction with alkyl- or arylisocyanate furnished pyrrolo[1,2,3,5]tetrazinones 174 (Scheme 54) [99].

3.3.3. 1,2,4,5-Tetrazine

An interesting example of the synthesis of pyrrolo[1,2-b][1,2,4,5]tetrazine derivatives 177 in good yields was described in [100,101] (Scheme 55). The reaction proceeds through the cyclization of hydrazidine hydrochloride 175 with halogen-substituted 5-hydroxyfuran-2(5H)-ones 176.
The dimerization of compounds bearing the N-aminopyridinium salts fragment 178 was reported (Scheme 56). These processes can take place in a basic medium [102,103].
Another method for the preparation of heteroanthracene derivatives 183 is the interaction of glyoxal-bis(hydrazone) 181 with glyoxal-bis(nitrosemicarbazone) 180 in water (Scheme 57) [104].
An interesting example of partial dearomatization/aromatization that results in the formation of tetrazo[1,2-b]indazoles 185187 was disclosed in [105] (Scheme 58). These structures exhibited low reduction potential, absorption in the visible (up to the near infrared) region, and intense fluorescence (in the case of bis-tetrazo[1,2-b]indazole (184)). It is noteworthy that both compounds 185187, in addition to their intrigue from a synthetic perspective, can be regarded as organic semiconductors, thus finding application in a diverse array of photonic and optoelectronic domains.
Another remarkable example of a strategy for the dearomatization of tetrazine derivatives is dearomatic [4+2]-cycloaddition of 1,2-dihydro-1,2,4,5-tetrazine-3,6-diones 188 to benzenes, naphthalenes, or N-heteroaromatic compounds 189 under visible light irradiation [106] (Scheme 59). In addition to a detailed description of the synthetic procedures, computational studies on retro-cycloaddition reactions were performed.

4. Conclusions

The literature analysis presented here is (1) a logical continuation of our previous review; (2) cannot be considered exhaustive; and (3) indicates that the preparation of saturated or partially saturated polyazocyclic skeletons lacking aromaticity is one of the most challenging problems in modern organic synthesis and catalysis. The three general strategies described in the literature, namely hydrogenation (hydrogen addition) and saturation (addition of molecules other than H2, e.g., hydroboration) of six-membered polyazo heterocycles, as well as construction of polyazocyclic compounds (including that via binding of two or more molecules, ring expansion reactions, and intramolecular and intermolecular cyclizations), have their own advantages and shortcomings. For instance, the process of classical hydrogenation, which is carried out in the presence of molecular hydrogen and a catalyst, necessitates elevated hydrogen pressure. In order to obtain chiral products, either a chiral catalyst or an additional chiral ligand should be employed, which must remain chiral throughout the entire process that can sometimes last for many hours. Saturation via hydroboration leads to the introduction of additional functional groups into the cyclic polyazoate moieties, which are not always desirable. Consequently, an additional reaction step in which these functional groups are substituted may be required. Despite their apparent simplicity, construction processes of the polyazole core through binding of two or more molecules, ring expansion reactions, as well as intramolecular and intermolecular cyclizations, contribute not only to the partial or complete saturation/formation of polyazo nonaromatic rings, but also lead to the introduction of additional functionalization into the target skeletons and require the use of catalysts of varying degrees of complexity, etc. The resolution of the aforementioned issues has been instrumental in propelling this research field forward, particularly in the last decade. However, the predominant focus of scientific groups on individual examples has resulted in an augmentation of intriguing techniques from a synthetic perspective. Nevertheless, this approach has not contributed to the systematic accumulation of results necessary for the formulation of a comprehensive theory, at least at this stage of research.

Author Contributions

Conceptualization, Y.Y.T. and A.V.I.; investigation, Y.Y.T., E.A.G. and A.V.I.; writing—original draft preparation, Y.Y.T., E.A.G. and A.V.I.; writing—review and editing, Y.Y.T. and A.V.I.; supervision, A.V.I.; project administration, Y.Y.T. All authors have read and agreed to the published version of the manuscript.

Funding

The reported study was performed within the framework of State Assignments Nos. 125020401307-9 and 125020601610-8.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

The authors are grateful to the Baikal Analytical Center for Collective Uses, SB RAS.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ACNAcetonitrile
AcOHAcetic acid
anti-HIV-1Active against human immunodeficiency virus
CbzClBenzyl chloroformate
cod1,5-Cyclooctadiene
DCE1,2-Dichloroethane
DCMDichloromethane
DCC1,3-Dicyclohexylcarbodiimine
dF(CF3)ppy2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine
DIPEAN,N-Diisopropylethylamine
DMAN,N-Dimethylaniline
DMFADimethylformamide
dtbpy4,4′-Di-tert-butyl-2,2′-bipyridine)
eeEnantiomeric excess
erEnantiomeric ratio
EtOAcEthyl acetate
HATHydrogen-atom transfer
HBpinPinacolborane
HRMSHigh-resolution mass spectrometry
ISCIntersystem crossing
LEDLight-emitting diode
LOHCLiquid organic hydrogen carriers
MeOCOClMethyl chloroformate
MTBEMethyl tert-butyl ether
MWMicrowave
NMPN-Methyl-2-pyrrolidone
OTfTriflate group
PMB4-Methoxybenzyl
PyPyridine
(R)-Segphos(R)-(+)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole, [4(R)-(4,4′-Bi-1,3-benzodioxole)-5,5′-diyl]bis[diphenylphosphine]
(R,S)-PPF-P-t-Bu2(R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine
(R Sp)-Josiphos{(R)-1-[(Sp)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine}[2-(2′-amino-1,1′-biphenyl)]palladium(II) methanesulfonate
(S,S)-f-Binaphane1,1′-Bis{(S)-4,5-dihydro-3H-binaphtho [1,2-c:2′,1′-e]phosphino}-ferrocene
(S)-BINAP(S)-(−)-2,2′-Bis(diphenylphosphino)-1,1′-binaphthalene
(S)-tol-BINAP(S)-(−)-2,2′-p-Tolyl-phosphino)-1,1′-binaphthyl, (S)-Tol-BINAP
SETSingle-electron transfer
(S)-Segphos(S)-(−)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole
(S)-Synphos6,6′-Bis(diphenylphosphino)-2,2′,3,3′-tetrahydro-5,5′-bibenzo[b][1,4]dioxine
(S)-DM-Segphos(S)-(−)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole
(S)-DTBM-Segphos(S)-(+)-5,5′-Bis[di(3,5-di-tert-butyl-4-methoxyphenyl)phosphino]-4,4′-bi-1,3-benzodioxole
(S)-Difluorphos(2,2,2′,2′-Tetrafluoro-4,4′-bibenzo[d][1,3]dioxole-5,5′-diyl)bis(diphenylphosphine)
TBABTetrabutylammonium bromide
tempTemperature
TFATrifluoroacetic acid
Troc2,2,2-Trichloroethoxycarbonyl
TrocCl2,2,2-Trichloroethoxycarbonyl chloride
Xantphos(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane)
USUltrasound
ΔBoiling or reflux
*Optically active fragment or center

References

  1. Asif, M. A Mini Review: Biological Significances of Nitrogen Hetero Atom Containing Heterocyclic Compounds. Int. J. Bioorganic Chem. 2017, 2, 146–152. [Google Scholar] [CrossRef]
  2. Cao, M.; Zhang, Y.; Peng, Z.; Jiang, J.; Gao, Y.; Hao, X. Schoberine B, an Alkaloid with an Unprecedented Straight C5 Side Chain, and Myriberine B from Myrioneuron Faberi. RSC Adv. 2016, 6, 10180–10184. [Google Scholar] [CrossRef]
  3. Tageldin, G.N.; Ibrahim, T.M.; Fahmy, S.M.; Ashour, H.M.; Khalil, M.A.; Nassra, R.A.; Labouta, I.M. Synthesis, Modeling and Biological Evaluation of Some Pyrazolo [3, 4-d] Anti-Inflammatory Agents. Bioorg. Chem. 2019, 90, 102844. [Google Scholar] [CrossRef]
  4. Zhang, J.; Cao, M.; Zhang, Y.; Li, X.; Gu, Y.; Li, X.N.; Di, Y.T.; Hao, X.J. Scalemic Myrionsumamide A, Tetracyclic Skeleton Alkaloids from Myrioneuron Effusum. RSC Adv. 2022, 12, 28147–28151. [Google Scholar] [CrossRef] [PubMed]
  5. Zhong, S.; Wandler, A.E.E.; Schepers, U.; Nieger, M.; Bräse, S. Synthesis of New Diketopiperazines, Thiolation to Thiodiketopiperazines, and Examination of Their ROS-Generating Properties. Eur. J. Org. Chem. 2015, 31, 6858–6871. [Google Scholar] [CrossRef]
  6. El-azab, A.S.; Abdel-aziz, A.A.; Bua, S.; Nocentini, A.; El-gendy, M.A. Bioorganic Chemistry Synthesis of Benzensulfonamides Linked to Quinazoline Scaffolds as Novel Carbonic Anhydrase Inhibitors. Bioorg. Chem. 2019, 87, 78–90. [Google Scholar] [CrossRef]
  7. Kirsanov, V.Y.; Rakhimova, E.B. Recent Advances in the Chemistry of Saturated Annulated Nitrogen-Containing Polycyclic Compounds. Int. J. Mol. Sci. 2022, 23, 15484. [Google Scholar] [CrossRef]
  8. Wang, R.; Yu, S.; Zhao, X.; Chen, Y.; Yang, B.; Wu, T.; Hao, C.; Zhao, D.; Cheng, M. Design, Synthesis, Biological Evaluation and Molecular Docking Study of Novel Thieno [3,2-d] Pyrimidine Derivatives as Potent FAK Inhibitors. Eur. J. Med. Chem. 2020, 188, 112024. [Google Scholar] [CrossRef]
  9. Zhang, Y.; Hou, Q.; Li, X.; Zhu, J.; Wang, W.; Li, B.; Zhao, L.; Xia, H. Enrichment of Novel Quinazoline Derivatives with High Antitumor Activity in Mitochondria Tracked by Its Self-Fluorescence. Eur. J. Med. Chem. 2019, 178, 417–432. [Google Scholar] [CrossRef]
  10. Sana, S.; Tokala, R.; Madanlal, D.; Nagesh, N.; Kumar, K. Bioorganic Chemistry Design and Synthesis of Substituted Dihydropyrimidinone Derivatives as Cytotoxic and Tubulin Polymerization Inhibitors. Bioorg. Chem. 2019, 93, 103317. [Google Scholar] [CrossRef] [PubMed]
  11. Yang, F.; Yu, L.; Diao, P.; Jian, X.; Zhou, M.; Jianga, C.S.; Youa, W.W.; Mab, W.F.; Zhao, P.L. Novel [1,2,4] Triazolo[1,5-a] Pyrimidine Derivatives as Potent Antitubulin Agents: Design, Multicomponent Synthesis and Antiproliferative Activities. Bioorg. Chem. 2019, 92, 103260. [Google Scholar] [CrossRef]
  12. Kerru, N.; Gummidi, L.; Maddila, S.; Gangu, K.K.; Jonnalagadda, S.B. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules 2020, 25, 1909. [Google Scholar] [CrossRef]
  13. Sanu, M.C.; Joseph, J.; Chacko, D.; Vinod, B.; Daisy, P.A. A Review on Six Membered Nitrogen Containing Heterocyclic Compounds with Various Biological Activities. Int. J. Pharm. Sci. Rev. Res. 2021, 69, 64–68. [Google Scholar] [CrossRef]
  14. Phei, F.; Lim, L.; Dolzhenko, A. V 1,3,5-Triazine-Based Analogues of Purine: From Isosteres to Privileged Scaffolds in Medicinal Chemistry. Eur. J. Med. Chem. 2014, 85, 371–390. [Google Scholar] [CrossRef]
  15. Bai, L.; Wei, C.; Zhang, J.; Song, R. Design, Synthesis, and Anti-PVY Biological Activity of 1,3,5-Triazine Derivatives Containing Piperazine Structure. Int. J. Mol. Sci. 2023, 24, 8280. [Google Scholar] [CrossRef]
  16. Hao, Y.; Wang, K.; Wang, Z.; Liu, Y.; Ma, D.; Wang, Q. Luotonin A and Its Derivatives as Novel Antiviral and Antiphytopathogenic Fungus Agents. J. Agric. Food Chem. 2020, 68, 8764–8773. [Google Scholar] [CrossRef]
  17. Kishimoto, S.; Tamura, T.; Okamoto, T.; Watanabe, K. Enantioselective Biosynthesis of (+)- and (−)-Auranthines. J. Am. Chem. Soc. 2025, 147, 10612–10617. [Google Scholar] [CrossRef] [PubMed]
  18. Singh, S.; Ghosh, S.K.; Mandal, M.K.; Masih, A.; Bhat, H.R.; Singh, U.P. 1,3,5-Triazine: A Versatile Pharmacophore with Diverse Biological Activities. Arch Pharm. 2021, 354, e2000363. [Google Scholar] [CrossRef] [PubMed]
  19. Barsegyan, Y.A.; Baranov, V.V.; Strelenko, Y.A.; Anikina, L.V.; Kravchenko, A.N.; Karnoukhova, V.A.; Kolotyrkina, N.G. Synthesis, Structure, and Biological Activity of 2,6-Disubstituted 2,3a,4a,6,7a,8a-Hexaazaperhydrocyclopenta [Def] Fluorene-4- Thioxo-8-Ones. Synthesis 2018, 50, 2099–2105. [Google Scholar] [CrossRef]
  20. Wang, D.; Chen, Q.A.; Lu, S.; Zhou, Y.G. Asymmetric Hydrogenation of Heteroarenes and Arenes. Chem. Rev. 2012, 112, 2557–2590. [Google Scholar] [CrossRef]
  21. Balakrishna, B.; Núñez-rico, J.L.; Vidal-ferran, A. Substrate Activation in the Catalytic Asymmetric Hydrogenation of N-Heteroarenes. Eur. J. Org. Chem. 2015, 2015, 5293–5303. [Google Scholar] [CrossRef]
  22. Titova, Y.Y.; Ivanov, A.V. Non-Classical Effective Methods for Reduction of Heteroaromatic Compounds. Russ. Chem. Rev. 2024, 93, RCR5149. [Google Scholar] [CrossRef]
  23. Kim, A.N.; Stoltz, B.M. Recent Advances in Homogeneous Catalysts for the Asymmetric Hydrogenation of Heteroarenes. ACS Catal. 2020, 10, 13834–13851. [Google Scholar] [CrossRef]
  24. Mamedov, V.A.; Zhukova, N.A. Recent Advances in the Synthesis of Indoles with Partially Hydro- Genated Benzene Ring (Tetrahydroindoles). Synthesis 2024, 56, 1207–1243. [Google Scholar] [CrossRef]
  25. Shi, L.; Zhou, Y.G. Catalytic, Enantioselective Hydrogenation of Heteroaromatic Compounds. In Organic Reactions; Denmark, S.E., Ed.; WILEY: Oxford, UK, 2018; Volume 96, pp. 1–226. [Google Scholar]
  26. Huang, W.; Yu, C.; Shi, L.; Zhou, Y. Iridium-Catalyzed Asymmetric Hydrogenation of Pyrrolo [1,2-a] Pyrazinium Salts. Org. Lett. 2014, 16, 3324–3327. [Google Scholar] [CrossRef]
  27. Zhang, Z.; Du, H. A Highly Cis-Selective and Enantioselective Metal-Free Hydrogenation of 2,3-Disubstituted Quinoxalines. Angew. Chem. Int. Ed. 2014, 54, 623–626. [Google Scholar] [CrossRef]
  28. Zhao, D.; Candish, L.; Paul, D.; Glorius, F. N-Heterocyclic Carbenes in Asymmetric Hydrogenation. ACS Catal. 2016, 6, 5978–5988. [Google Scholar] [CrossRef]
  29. Higashida, K.; Nagae, H.; Mashima, K. Iridium-Catalyzed Asymmetric Hydrogenation of Tosylamido- Substituted Pyrazines for Constructing Chiral Tetrahydropyra- Zines with an Amidine Skelton. Adv. Synth. Catal. 2016, 358, 3949–3954. [Google Scholar] [CrossRef]
  30. Wu, X.; Li, X.; Zanotti-Gerosa, A.; Pettman, A.; Liu, J.; Mills, A.J.; Xiao, J. RhIII- and IrIII-Catalyzed Asymmetric Transfer Hydrogenation of Ketones in Water. Chem. A Eur. J. 2008, 14, 2209–2222. [Google Scholar] [CrossRef] [PubMed]
  31. Fischer, T.; Bamberger, J.; Mancheño, O.G. Asymmetric Nucleophilic Dearomatization of Diazarenes by Anion-Binding Catalysis. Org. Biomol. Chem. 2016, 14, 5794–5802. [Google Scholar] [CrossRef] [PubMed]
  32. Park, S.; Chang, S. Catalytic Dearomatization of N-Heteroarenes with Silicon and Boron Compounds. Angew. Chem. Int. Ed. 2017, 56, 2–21. [Google Scholar] [CrossRef]
  33. Liu, H.; Khononov, M.; Eisen, M.S. Catalytic 1,2-Regioselective Dearomatization of N-Heteroaromatics via a Hydroboration. ACS Catal. 2018, 8, 3673–3677. [Google Scholar] [CrossRef]
  34. Ni, Q.; Chen, Y.; Ma, Y. Synthesis Recent Progress in Base-Metal-Catalyzed Dearomative Reaction of N -Heteroarenes. Synthesis 2025, 57, 2289–2306. [Google Scholar] [CrossRef]
  35. Ketelboeter, D.R.; Pappoppula, M.; Aponick, A. Chemoselective Diazine Dearomatizationn: The Catalytic Enantioselective Dearomatization of Pyrazine. J. Am. Chem. Soc. 2024, 146, 11610–11615. [Google Scholar] [CrossRef]
  36. Resch, V.; Seidler, C.; Chen, B.; Degeling, I.; Hanefeld, U. On the Michael Addition of Water to α,β-Unsaturated Ketones Using Amino Acids. Eur. J. Org. Chem. 2013, 2013, 7697–7704. [Google Scholar] [CrossRef]
  37. Li, K.; Meng, F.; Jiang, W.; Shi, L. ZrCl4-Catalyzed Nucleophilic Dearomatization of 2-Hydroxy-Pyrimidines: A Concise Synthesis of Novel 3,4-Dihydropyrimidin-2 (1H)-Ones Containing a Phosphonic Ester Group. Tetrahedron Lett. 2021, 73, 153149. [Google Scholar] [CrossRef]
  38. Wanga, W.; Menga, W.; Du, H. B(C6F5)3-Catalyzed Metal-Free Hydrogenations of 3,6- Diarylpyridazines. Dalt. Trans. 2016, 45, 5945–5948. [Google Scholar] [CrossRef] [PubMed]
  39. Kuwano, R.; Hashiguchi, Y.; Ikeda, R.; Ishizuka, K. Catalytic Asymmetric Hydrogenation of Pyrimidines. Angew. Chem. Int. Ed. 2015, 54, 2393–2396. [Google Scholar] [CrossRef]
  40. Xie, C.; Xiao, G.; Guo, Q.; Wu, X.; Zi, G.; Ding, W.; Hou, G. Highly Enantioselective Rh-Catalyzed Asymmetric Reductive Dearomatization of Multi-Nitrogen. Chem. Sci. 2023, 14, 9048–9054. [Google Scholar] [CrossRef]
  41. Chen, M.; Li, H.; Wang, Y.; Wu, B.; Liu, Z.; Lai, X.; Deerberg, J.; Zhou, Y. Iridium-Catalyzed Asymmetric Hydrogenation of Heteroaromatics with Multiple N Atoms via Substrate Activation: An Entry to 4,5,6,7- Tetrahydropyrazolo [1,5-a] Pyrimidine-3-Carbonitrile Core of a Potent BTK Inhibitor. J. Org. Chem. 2024, 89, 4336–4348. [Google Scholar] [CrossRef] [PubMed]
  42. Yang, Z.; Chen, Y.; Wan, L.; Li, Y.; Chen, D.; Tao, J.; Tang, P.; Chen, F. Iridium-Catalyzed Asymmetric, Complete Hydrogenation of Pyrimidinium Salts under Batch and Flow. Green Chem. 2024, 26, 317–322. [Google Scholar] [CrossRef]
  43. Tautomers, P.-H.; Feng, G.; Chen, M.; Shi, L.; Zhou, Y. Asymmetric Hydrogenation Facile Synthesis of Chiral Cyclic Ureas through Hydrogenation of 2-Hydroxypyrimidine/Pyrimidin-2(1H)-One Tautomers. Angew. Chem. Int. Ed. 2018, 57, 5853–5857. [Google Scholar] [CrossRef]
  44. Huang, W.; Liu, L.; Wu, B.; Feng, G.; Wang, B.; Zhou, Y. Synthesis of Chiral Piperazines via Hydrogenation of Pyrazines Activated by Alkyl Halides. Org. Lett. 2016, 18, 3082–3085. [Google Scholar] [CrossRef]
  45. Guo, Q.; Xie, C.; Zi, G.; Lai, X.; Deerberg, J.; Hou, G. Ir-Catalyzed Asymmetric Hydrogenation of N-Fused Heteroarenes with High Nitrogen Density: An Access to Chiral 2,5-Disubstituted 5,6-Dihydropyrrolo [1,2-a] [1,2,4] Triazolo [5,1-c] Pyrazines. Org. Lett. 2024, 26, 7363–7369. [Google Scholar] [CrossRef]
  46. Chen, A.Y.; He, Y.; Zhang, S.; Miao, T.; Fan, Q. Rapid Construction of Structurally Diverse Quinolizidines, Indolizidines and Their Analogues via Ruthenium-Catalyzed Asymmetric Cascade Hydrogenation/Reductive Amination. Angew. Chemie Int. Ed. 2019, 58, 3809–3813. [Google Scholar] [CrossRef]
  47. Feng, G.; Zhao, Z.; Shi, L.; Zhou, Y. Synthesis of Chiral Piperazin-2-Ones through Palladium-Catalyzed Asymmetric Hydrogenation of Pyrazin-2-Ols. Org. Chem. Front. 2021, 8, 6273–6278. [Google Scholar] [CrossRef]
  48. Voutchkova, A.M.; Gnanamgari, D.; Jakobsche, C.E.; Butler, C.; Miller, S.J.; Parr, J.; Crabtree, R.H. Selective Partial Reduction of Quinolines: Hydrosilylation vs. Transfer Hydrogenation. J. Organomet. Chem. 2008, 693, 1815–1821. [Google Scholar] [CrossRef]
  49. Manas, M.G.; Sharninghausen, L.S.; Crabtree, R.H. Experimental and Computational Studies of Borohydride Catalyzed Hydrosilylation of a Variety of C=O and C=N Functionalities Including Esters, Amides and Heteroarenes. New J. Chem. 2014, 38, 1694–1700. [Google Scholar] [CrossRef]
  50. Liu, T.; He, J.; Zhang, Y. Regioselective 1,2-Hydroboration of N-Heteroarenes Using a Potassium-Based Catalyst. Org. Chem. Front. 2019, 6, 2749–2755. [Google Scholar] [CrossRef]
  51. Yang, C.H.; Chen, X.; Li, H.; Wei, W.; Yang, Z.; Chang, J. Iodine Catalyzed Reduction of Quinolines under Mild Reaction Conditions. Chem. Commun. 2018, 54, 8622–8625. [Google Scholar] [CrossRef]
  52. Shakhman, D.; Dmitrienko, A.; Pilkington, M.; Nikonov, G.I. Selective Zinc-Catalyzed 1,2-Hydroboration of N-Heteroaromatics via a Non-Hydride Mechanism. Eur. J. Inorg. Chem. 2023, 26, e202300293. [Google Scholar] [CrossRef]
  53. Velmurugan, P.; Eisen, M.S.; Ghatak, T. Recent Strategies and Developments in the Hydroboration of N-Heteroarenes Mediated by Transition and Rare-Earth Metal Complexes. Inorganica Chim. Acta 2025, 580, 122594. [Google Scholar] [CrossRef]
  54. Shida, N.; Shimizu, Y.; Yonezawa, A.; Harada, J.; Furutani, Y.; Muto, Y.; Kurihara, R.; Kondo, J.N.; Sato, E.; Mitsudo, K.; et al. Electrocatalytic Hydrogenation of Pyridines and Other Nitrogen- Containing Aromatic Compounds. J. Am. Chem. Soc. 2024, 146, 30212–30221. [Google Scholar] [CrossRef] [PubMed]
  55. Chatterjee, A.; Konig, B. Birch-Type Photoreduction of Arenes and Heteroarenes by Sensitized Electron Transfer. Angew. Chem. Int. Ed. 2019, 58, 14289–14294. [Google Scholar] [CrossRef] [PubMed]
  56. Moore, J.; Volker, E.J.; Kopay, C. Heterocyclic Studies. 34. Toluenesulfonyl Derivatives of 2,3-Dihydro-5-Methyl-(i-Phenyl-1,2-Diazepin-4-One, Rearrangement to a 1,4-Dihydropyridazine. J. Org. Chem. 1971, 36, 2676–2680. [Google Scholar] [CrossRef]
  57. Shabalin, D.A.; Dvorko, Y.; Zolotareva, E.E.; Ushakov, I.A.; Vashchenko, A.V.; Schmidt, E.Y.; Trofimov, B.A. Metal-Free Selective Synthesis of 1,4-Dihydropyridazines from Hydroxypyrrolines and Hydrazines. Eur. J. Org. Chem. 2017, 2017, 4004–4010. [Google Scholar] [CrossRef]
  58. Guo, S.; Wang, J.; Fan, X.; Zhang, X.; Guo, D. Synthesis of Pyrazolo [1,5-c] Quinazoline Derivatives through Copper-Catalyzed Tandem Reaction of 5-(2-Bromoaryl)-1H-pyrazoles with Carbonyl Compounds and Aqueous Ammonia. J. Org. Chem. 2013, 78, 3262–3270. [Google Scholar] [CrossRef]
  59. Shi, R.; Gao, L.; Chen, W.; Shi, Y.; Cao, Z.; Zheng, Y.; Liu, J. Formal [2 + 2 + 2] Cycloaddition Reaction of 1,3,5-Triazinanes with Diethyl Acetylene Dicarboxylate: Approach to Tetrahydropyrimidines. Eur. J. Org. Chem. 2021, 2021, 5941–5945. [Google Scholar] [CrossRef]
  60. Chen, L.; Liu, K.; Sun, J. Catalyst-Free Synthesis of Tetrahydropyrimidines via Formal [3+3]-Cycloaddition of Imines with 1,3,5- Hexahydro-1,3,5-Triazines. RSC Adv. 2018, 8, 5532–5535. [Google Scholar] [CrossRef]
  61. Rong, L.; Lai, C.; Han, S.; Liao, J.; Liu, C.; Li, X.; Huang, J. Additive-Free Construction of Tetrahydropyrimidine Skeleton by Using 1,3,5-Triazinane as Four-Atom Synthon. J. Org. Chem. 2024, 89, 9496–9501. [Google Scholar] [CrossRef]
  62. Han, S.; Fang, C.; Li, S.; Mo, X.; Xu, Y.; An, B.; Cheng, B. Divergent Sc (OTf)3 -Catalyzed Tandem Cyclization of o-Hydroxyphenyl Enaminones with 1,3,5-Triazinanes: Access to C3-Aminomethyl Chromones and Tetrahydropyrimidines. Asian J. Org. Chem. 2024, 13, e202400391. [Google Scholar] [CrossRef]
  63. Duan, S.; Meng, H.; Jablasone, S.T.; Luo, H.; Xu, Z.; Li, C. Rhodium (II)-Catalyzed [4+2] Annulation of Ester-Tethered 1-Sulfonyl-1,2,3-Triazoles and Hexahydro-1,3,5-Triazines. Asian J. Org. Chem. 2021, 10, 1076–1080. [Google Scholar] [CrossRef]
  64. Xie, W.; Wang, C.; Xu, J. Reaction of 1,3,5-Triazinanes with Phosphoryl Diazomethanes: Access to 5-Phosphoryl-1,2,3,4-Tetrahydropyrimidines. Org. Lett. 2024, 26, 3391–3396. [Google Scholar] [CrossRef]
  65. Tabor, W.; Katsogiannou, A.; Karta, D.; Andrianopoulou, E.; Berlicki, Ł.; Vassiliou, S.; Grabowiecka, A. Exploration of Thiourea-Based Scaffolds for the Construction of Bacterial Ureases Inhibitors. ACS Omega 2023, 8, 28783–28796. [Google Scholar] [CrossRef] [PubMed]
  66. Wang, W.; Zheng, J.; Zhao, S. Chemoselective Synthesis of Tetrahydropyrimidines and Dihydropyrrolidones through Three-Component Reaction of Amines, 1,3, 5-Triazinanes, and Alkyne Esters. Eur. J. Org. Chem. 2025, 28, e202401400. [Google Scholar] [CrossRef]
  67. Wang, T.; Zhang, B.; Hu, L.; Sun, H.; Wang, Y.; Zhai, H.; Cheng, B. Synthesis of Chromeno [2,3-d] Pyrimidin-5-One Derivatives from 1,3,5-Triazinanes via Two Different Reaction Pathways. J. Org. Chem. 2022, 87, 1348–1356. [Google Scholar] [CrossRef]
  68. Zheng, Y.; Tu, L.; Li, N.; Huang, R.; Feng, T.; Sun, H.; Li, Z.; Liu, J. Inverse-Electron-Demand [4+2]-Cycloaddition of 1,3,5- Triazinanes: Facile Approaches to Tetrahydroquinazolines Yongsheng. Adv. Synth. Catal. 2019, 361, 44–48. [Google Scholar] [CrossRef]
  69. Ji, D.; Wang, C.; Sun, J. Asymmetric [4+2]-Cycloaddition of Copper−Allenylidenes with Hexahydro-1,3,5-Triazines: Access to Chiral Tetrahydroquinazolines. Org. Lett. 2018, 20, 3710–3713. [Google Scholar] [CrossRef]
  70. Jo, H.Y.; Lee, J.M.; Pietrasiak, E.; Lee, E.; Rhee, Y.H.; Park, J. Generation of N−H Imines from A-Azidocarboxylic Acids through Ru-Catalyzed Decarboxylation. J. Org. Chem. 2021, 86, 17409–17417. [Google Scholar] [CrossRef]
  71. Tian, Y.; Chen, Z.; Su, K.; Zheng, Y.; Liu, J. [2 + 2 + 1 + 1] Cycloaddition Reaction of 1,3,5-Triazinanes with Methylene Compounds: Approach to Hexahydropyrimidines. Adv. Synth. Catal. 2023, 365, 3909–3914. [Google Scholar] [CrossRef]
  72. Yang, D.; Wang, Y.; Zhang, C.; Luo, Y.; Zhu, X.; Zhao, S.; Fu, W.; Cheng, B.; Zhai, H.; Wang, T. Shifting Access from Pyrimidine-Spirofused to Fused Benzoheterocycles by Modifying the Activated Group Position. Adv. Synth. Catal. 2024, 366, 1096–1100. [Google Scholar] [CrossRef]
  73. Wang, C.; Wang, Q.; Ren, M.; Xue, Y.; Wang, Z.; Hou, X.H.; Ma, Z.W.; Xie, Y.X.; Chen, Y.J. [1 + 5] Cyclization of Indoline-Derived Azadienes with 1,3,5- Triazinanes: An Efficient Protocol for the Synthesis of Indoline-Spiro-Hexahydropyrimidines. Chem. Eur. J. 2025, 31, e202404277. [Google Scholar] [CrossRef]
  74. Shipilovskikh, S.A.; Rubtsov, A.E. One-Pot Synthesis of Thieno [3,2-e] Pyrrolo [1,2-a] Pyrimidine Derivative Scaffold: A Valuable Source of PARP-1 Inhibitors. J. Org. Chem. 2019, 84, 15788–15796. [Google Scholar] [CrossRef] [PubMed]
  75. Javahershenas, R.; Khalafy, J. One-Pot, Three-Component Synthesis of Pyrrolo [2,3-d] Pyrimidine Derivatives. J. Mex. Chem. Soc. 2018, 62, 1–9. [Google Scholar] [CrossRef]
  76. Yang, P.; Wang, Q.; Cui, B.H.; Zhang, X.D.; Liu, H.; Zhang, Y.Y.; Liu, J.L.; Huang, W.Y.; Liang, R.X.; Jia, Y.X. Enantioselective Dearomative [3 + 2] Umpolung Annulation of N-Heteroarenes with Alkynes. J. Am. Chem. Soc. 2022, 144, 1087–1093. [Google Scholar] [CrossRef] [PubMed]
  77. Xiong, B.; Zhang, S.; Chen, L.; Li, B.; Jiang, H.; Zhang, M. An Annulative Transfer Hydrogenation Strategy Enables Straightforward Access to Tetrahydro Fused-Pyrazine Derivatives. Chem. Commun. 2016, 52, 10636–10639. [Google Scholar] [CrossRef]
  78. Jeong, E.; Heo, J.; Park, S.; Chang, S. Alkoxide-Promoted Selective Hydroboration of N-Heteroarenes: Pivotal Roles of in Situ Generated BH3 in the Dearomatization Process. Chem. A Eur. J. 2019, 25, 6320–6325. [Google Scholar] [CrossRef]
  79. Moradi, L.; Piltan, M.; Rostami, H.; Abasi, G. One-Pot Synthesis of Pyrrolo [1,2-a] Pyrazines via Three Component Reaction of Ethylenediamine, Acetylenic Esters and Nitrostyrene Derivatives. Chinese Chem. Lett. 2013, 24, 740–742. [Google Scholar] [CrossRef]
  80. Wippert, N.; Nieger, M.; Herlan, C.; Jung, N.; Bräse, S. Synthesis of New Pyrazolo [1,2,3] Triazines by Cyclative Cleavage of Pyrazolyltriazenes. Beilstein J. Org. Chem. 2021, 17, 2773–2780. [Google Scholar] [CrossRef]
  81. Parrino, B.; Carbone, A.; Muscarella, M.; Spano, V.; Montalbano, A.; Barraja, P.; Salvador, A.; Vedaldi, D.; Cirrincione, G.; Diana, P. 11H-Pyrido [3’,2’:4,5] Pyrrolo [3,2-c] Cinnoline and Pyrido [3’,2’:4,5] Pyrrolo [1,2- c] [1,2,3] Benzotriazine: Two New Ring Systems with Antitumor Activity. J. Med. Chem. 2014, 57, 9495–9511. [Google Scholar] [CrossRef]
  82. Pang, X.; Zhao, L.; Zhou, D.; He, P.Y.; An, Z.; Ni, J.X.; Yan, R. Tert-Butyl Nitrite (TBN) as the N Atom Source for the Synthesis of Substituted Cinnolines with 2-Vinylanilines and a Relevant Mechanism Was Studied. Org. Biomol. Chem. 2017, 15, 6318–6322. [Google Scholar] [CrossRef] [PubMed]
  83. Li, N.; Li, B.; Yu, F.; Zhang, X.; Fan, X. Synthesis of Pyrazolidinone-Fused Benzotriazines through C−H/ N−H Bond Functionalization of 1-Phenylpyrazolidinones with Oxadiazolones. J. Org. Chem. 2023, 88, 8179–8191. [Google Scholar] [CrossRef] [PubMed]
  84. Wang, D.; Liu, J.; Guan, Y.; Guo, H. Dearomative [4+2] Annulation of Electron-Poor N-Heteroarenes with Azoalkenes for Access to Polycyclic Tetrahydro-1,2,4-Triazines. Org. Lett. 2023, 25, 3543–3547. [Google Scholar] [CrossRef]
  85. Li, X.; Romero, M.D.; Tcaturian, S.; Kurpiewska, K.; Dömling, A. N-Edited Guanine Isosteres. J. Org. Chem. 2023, 88, 9823–9834. [Google Scholar] [CrossRef]
  86. Fang, Z.; Jin, Q.; Wang, X.; Ning, Y. Metal-Free [2+1+3] Cycloaddition of Trifluoroacetaldehyde N-Sulfonylhydrazones with Hexahydro-1,3,5-Triazines Leading to Trifluoromethylated 2,3,4,5-Tetrahydro-1,2,4-Triazines. J. Org. Chem. 2022, 87, 2966–2974. [Google Scholar] [CrossRef]
  87. Tahmasby, M.; Darehkordi, A.; Mohammadi, M.; Nejadkhorasani, F. Pyrido Triazin-Nucleus Synthesis and Theoretical Studies: 2,3,6-Trioxo-8-Aryl-1,3,4,6-Tetrahydro-] 2H [Pyrido] 1,2-b][1,2,4 [Triazin-7,9-Dicarbonitryl Derivatives. J. Mol. Struct. 2020, 1224, 129032. [Google Scholar] [CrossRef]
  88. Traynor, J.R.; Wibberley, D.G. Pyrrolo [1,2-a] [1,3,5] Triazine-2,4 (1H,3H)-Diones. Part II. Synthesis from 3,4-Disubstituted 2-Aminopyrroles. J. Chem. Soc. Perkin Trans. 1 1974, 1974, 1786–1788. [Google Scholar] [CrossRef]
  89. Verhoeven, J.; Reddy, B.N.; Meerpoel, L.; Willem, J.; Verniest, G. Synthesis and Transformations of Pyrrolo [1,2-a] [1,3,5]-Triazines. Tetrahedron Lett. 2018, 59, 4537–4539. [Google Scholar] [CrossRef]
  90. Wingard, L.A.; Johnson, E.C.; Sabatini, J.J. Efficient Method for the Cycloaminomethylation of Glycoluril. Tetrahedron Lett. 2016, 57, 1681–1682. [Google Scholar] [CrossRef]
  91. Salkeeva, L.K.; Shibaeva, A.K.; Bakibaev, A.A.; Taishibekova, E.K.; Minaevaa, E.V.; Zhortarovaa, A.A.; Sal’keeva, A.K. New Heterocycles Based on Tetramethylol Glycoluril. Russ. J. Gen. Chem. 2014, 84, 344–345. [Google Scholar] [CrossRef]
  92. Khairullina, R.R.; Geniyatova, A.R.; Meshcheryakova, E.S.; Khalilov, L.M.; Ibragimov, A.G.; Dzhemilev, U.M. Catalytic Cycloaminomethylation of Ureas and Thioureas with N,N-Bis (Methoxymethyl) Alkanamines. Russ. J. Org. Chem. 2015, 51, 118–122. [Google Scholar] [CrossRef]
  93. Kravchenko, A.N.; Chikunov, I.E.; Lyssenko, K.A.; Baranov, V. V Glycolurils in α-Ureido- and α-Aminoalkylation Reactions. 3**. N-(Hydroxymethyl) Glycolurils in Reactions with Aliphatic Amines and Amino Acids. Chem. Heterocycl. Compd. 2014, 50, 1322–1331. [Google Scholar] [CrossRef]
  94. Rakhimova, E.B.; Ismagilov, R.A.; Meshcheryakova, E.S.; Khalilov, L.M.; Ibragimov, A.G.; Dzhemilev, U.M. An Efficient Catalytic Method for the Synthesis of 2, 7-Dialkyl-2,3a,5a,7,8a,10a-Hexaazaperhydropyrenes. Tetrahedron Lett. 2014, 55, 6367–6369. [Google Scholar] [CrossRef]
  95. Rakhimova, E.B.; Kirsanov, V.Y.; Meshcheryakova, E.S.; Khalilov, L.M.; Kutepov, B.I.; Ibragimov, A.G.; Dzhemilev, U.M. One-Pot Catalytic Synthesis of 2,7-Bis-Substituted 4,9(10)-Dimethyl-2,3a,5a,7,8a,10a-Hexaazaperhydropyrenes. Tetrahedron 2017, 73, 6880–6886. [Google Scholar] [CrossRef]
  96. Rakhimova, E.B.; Ibragimov, A.G.; Dzhemilev, U.M. Efficient Catalytic Synthesis of 2,7-Diaryl (Hetaryl)-4,9-Dimethyl-Perhydro-2,3a,5a,7,8a,10a-Hexaazapyrenes. Russ. J. Org. Chem. 2018, 54, 1085–1089. [Google Scholar] [CrossRef]
  97. Klenov, M.S.; Voronin, A.A.; Churakov, A.M.; Tartakovsky, V.A. Advances in the Chemistry of 1,2,3,4-Tetrazines. Russ. Chem. Rev. 2023, 92, RCR5089. [Google Scholar] [CrossRef]
  98. Renault, A.; Joucla, L.; Lacôte, E. Catalytic Aerobic Oxidation of Hydrazines into 2-Tetrazenes. Eur. J. Org. Chem. 2022, 2022, e202200265. [Google Scholar] [CrossRef]
  99. Diana, P.; Barraja, P.; Lauria, A.; Montalbano, A.; Almerico, A.M.; Dattolo, G.; Cirrincione, G. Pyrrolo [2,1-d] [1,2,3,5] Tetrazine-4(3H)-Ones, a New Class of Azolotetrazines with Potent Antitumor Activity. Bioorg. Med. Chem. 2003, 11, 2371–2380. [Google Scholar] [CrossRef] [PubMed]
  100. Degen, H.-J.; Hailer, S.; Heeg, K.; Neunhoeffer, H. Hydrazidine, III. Synthese von 1,2,4,5-Tetrazino [3,2-a] Isoindolen. Chem. Ber. 1979, 112, 1981–1990. [Google Scholar] [CrossRef]
  101. Neunhoeffer, H.; Karafiat, U.; Kohler, G.; Sowa, B.; Hydrazidine, V. Synthese Und Reaktionen Aromatischer Und Aliphatischer Hydrazidine Und Deren N1-Substituierter Derivate. Liebigs Ann. Chemie 1992, 1992, 115–126. [Google Scholar] [CrossRef]
  102. Powell, B.F.; Overberger, C.G.; Anselme, J.-P. Hydrosulfite Reduction of N-Nitroso-1,2,3,4-Etrahydroisoquinolines and Oxidation of N-Amino-l,2,3,4 Tetrahydroisoquinolines. J. Heterocycl. Chem. 1983, 20, 121–128. [Google Scholar] [CrossRef]
  103. Lempert, K.; Fetter, J.; Nyitrai, J.; Bertha, F.; Møller, J. Electron-Deficient Heteroaromatic Ammonioamidates. Part 27. Quinazolinioamidates. Part 14. N-Amination of Some Quinazoline Derivatives and Some Reactions of the Resulting Quinazolinioamides. J. Chem. Soc. Perkin Trans. 1 1986, 1986, 269–275. [Google Scholar] [CrossRef]
  104. Glukhacheva, V.S.; Il’yasov, S.G.; Obraztsov, A.A.; Gatilov, Y.V.; Eltsov, I.V. A New Synthetic Route to Heteroanthracenes. Eur. J. Org. Chem. 2018, 2018, 1265–1273. [Google Scholar] [CrossRef]
  105. Daher, A.; Bousfiha, A.; Tolbatov, I.; Mboyi, C.D.; Cattey, H.; Roisnel, T.; Fleurat-lessard, P.; Hissler, M.; Hierso, J.; Bouit, P.-A.; et al. Tetrazo [1,2-b] Indazoles: Straightforward Access to Nitrogen-Rich Polyaromatics from s-Tetrazines Angewandte. Angew. Chem. Int. Ed. 2023, 62, e202300571. [Google Scholar] [CrossRef] [PubMed]
  106. Ikeda, K.; Kojima, R.; Kawai, K.; Murakami, T.; Kikuchi, T.; Kojima, M.; Yoshino, T.; Matsunaga, S. Formation of Isolable Dearomatized [4+2] Cycloadducts from Benzenes, Naphthalenes, and N-Heterocycles Using 1,2-Dihydro-1,2,4,5-Tetrazine-3,6-Diones as Arenophiles under Visible Light Irradiation. J. Am. Chem. Soc. 2023, 145, 9326–9333. [Google Scholar] [CrossRef]
Figure 1. Examples of registered drugs containing saturated or partially saturated analogs of polyazoaromatic heterocycles (the target polyazole nonaromatic cores are highlighted in red).
Figure 1. Examples of registered drugs containing saturated or partially saturated analogs of polyazoaromatic heterocycles (the target polyazole nonaromatic cores are highlighted in red).
Molecules 30 03911 g001
Figure 2. General methods for the synthesis of nonaromatic polyazocyclic compounds.
Figure 2. General methods for the synthesis of nonaromatic polyazocyclic compounds.
Molecules 30 03911 g002
Scheme 1. (a) Borane-catalyzed hydrogenation of 3,6-disubstituted pyridazines; (b) a plausible catalytic cycle, according to [38].
Scheme 1. (a) Borane-catalyzed hydrogenation of 3,6-disubstituted pyridazines; (b) a plausible catalytic cycle, according to [38].
Molecules 30 03911 sch001
Scheme 2. Catalytic asymmetric hydrogenation of 4-methyl-2-phenylpyrimidine, according to [39]. R1 = Ph, 4-CF3C6H4, 4-MeOC6H4, 2-FC6H4, 2-ClC6H4, 2-MeC6H4, 2-MeOC6H4, Me, NMe2; R2 = Me, Et, c-Hex, t-Bu, Ph, 4-CF3C6H4, 4-MeOC6H4, CH2OAc, CF3, CO2Et, Ph.
Scheme 2. Catalytic asymmetric hydrogenation of 4-methyl-2-phenylpyrimidine, according to [39]. R1 = Ph, 4-CF3C6H4, 4-MeOC6H4, 2-FC6H4, 2-ClC6H4, 2-MeC6H4, 2-MeOC6H4, Me, NMe2; R2 = Me, Et, c-Hex, t-Bu, Ph, 4-CF3C6H4, 4-MeOC6H4, CH2OAc, CF3, CO2Et, Ph.
Molecules 30 03911 sch002
Scheme 3. (a) Rh-catalyzed asymmetric hydrogenation of 4,5-dihydropyr-azolo [1,5-a]pyrimidine (* symbol denotes an optically active center); (b) proposed catalytic cycle, according to [40]. R1 = Ph, 3-Me-C6H4, 3-MeO-C6H4, 4-tBu-C6H4, 3-X-C6H4 (X = Cl, Br, F), 4-X-C6H4 (X = Cl, Br, F) and others; R2 = NC, EtOOC; R3 = Ph, 2-Me-C6H4, 2-MeO-C6H4, 3-Me-C6H4, 4-Me-C6H4, 4-MeO-C6H4 and others; R3 = H; and Ar = 3,5-tBu-4-MeO-C6H2; *—optically active center.
Scheme 3. (a) Rh-catalyzed asymmetric hydrogenation of 4,5-dihydropyr-azolo [1,5-a]pyrimidine (* symbol denotes an optically active center); (b) proposed catalytic cycle, according to [40]. R1 = Ph, 3-Me-C6H4, 3-MeO-C6H4, 4-tBu-C6H4, 3-X-C6H4 (X = Cl, Br, F), 4-X-C6H4 (X = Cl, Br, F) and others; R2 = NC, EtOOC; R3 = Ph, 2-Me-C6H4, 2-MeO-C6H4, 3-Me-C6H4, 4-Me-C6H4, 4-MeO-C6H4 and others; R3 = H; and Ar = 3,5-tBu-4-MeO-C6H2; *—optically active center.
Molecules 30 03911 sch003
Scheme 4. (a) Ir-catalyzed asymmetric hydrogenation of 2,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile; (b) proposed reaction pathway, according to [41]. R1 = Ph, 2-Me-C6H4, 1-Me-C6H4, 3-X-C6H4 (X = Me, Br, SMe, CF3) and others; R2 = Me, Ph, 2-Me-C6H4, 3-X-C6H4 (X = Me, MeO, CF3) and others; *—optically active center.
Scheme 4. (a) Ir-catalyzed asymmetric hydrogenation of 2,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile; (b) proposed reaction pathway, according to [41]. R1 = Ph, 2-Me-C6H4, 1-Me-C6H4, 3-X-C6H4 (X = Me, Br, SMe, CF3) and others; R2 = Me, Ph, 2-Me-C6H4, 3-X-C6H4 (X = Me, MeO, CF3) and others; *—optically active center.
Molecules 30 03911 sch004
Scheme 5. Ir-catalyzed asymmetric hydrogenation of the N-benzyl-4-substituted pyrimidinium salts, according to [42]. R1 = Ph, CH3-C6H4, i-Pr-C6H4, CH3O-C6H4, O2N-C6H4, CF3-C6H4, CN-C6H4, (CH3)2C6H3, X-C6H4 (X = Cl, Br, F).
Scheme 5. Ir-catalyzed asymmetric hydrogenation of the N-benzyl-4-substituted pyrimidinium salts, according to [42]. R1 = Ph, CH3-C6H4, i-Pr-C6H4, CH3O-C6H4, O2N-C6H4, CF3-C6H4, CN-C6H4, (CH3)2C6H3, X-C6H4 (X = Cl, Br, F).
Molecules 30 03911 sch005
Scheme 6. Pd-catalyzed asymmetric hydrogenation of 2-hydroxypyrimidines, according to [43]. R = Ph, CH3-C6H4, (CH3)2C6H3, X-C6H4 (X = Cl, Br, F), n-Pr-C6H4, MeO-C6H4, CF3-C6H4, (OCH3)2C6H3.
Scheme 6. Pd-catalyzed asymmetric hydrogenation of 2-hydroxypyrimidines, according to [43]. R = Ph, CH3-C6H4, (CH3)2C6H3, X-C6H4 (X = Cl, Br, F), n-Pr-C6H4, MeO-C6H4, CF3-C6H4, (OCH3)2C6H3.
Molecules 30 03911 sch006
Scheme 7. Ir-catalyzed hydrogenation of (a) 3-substituted and (b) 3,5-disubstituted pyrazinium salts, according to [44]. Ar = Ph, 2-i-PrO2CC6H4; R = Ph, 3-MeC6H4, 4-MeC6H4, 3,5-Me2C6H4, 3-MeOC6H4, X-C6H4 (X = Cl, Br, F), 4-CF3C6H4, 4-PhC6H4, and others; R1 = Me, Et, n-Pr, n-Bu, i-Bu, cyclopropyl; and R2 = Ph, 3-MeC6H4, 4-MeC6H4, 3,5-Me2C6H4, 3-MeOC6H4, 4-MeOC6H4, 4-BuOC6H4, X-C6H4 (X = Cl, F), 4-CF3C6H4, 4-C6H5-C6H4, and others.
Scheme 7. Ir-catalyzed hydrogenation of (a) 3-substituted and (b) 3,5-disubstituted pyrazinium salts, according to [44]. Ar = Ph, 2-i-PrO2CC6H4; R = Ph, 3-MeC6H4, 4-MeC6H4, 3,5-Me2C6H4, 3-MeOC6H4, X-C6H4 (X = Cl, Br, F), 4-CF3C6H4, 4-PhC6H4, and others; R1 = Me, Et, n-Pr, n-Bu, i-Bu, cyclopropyl; and R2 = Ph, 3-MeC6H4, 4-MeC6H4, 3,5-Me2C6H4, 3-MeOC6H4, 4-MeOC6H4, 4-BuOC6H4, X-C6H4 (X = Cl, F), 4-CF3C6H4, 4-C6H5-C6H4, and others.
Molecules 30 03911 sch007
Scheme 8. Ir-catalyzed asymmetric hydrogenation of pyrrolo [1,2-a]pyrazinium salts, according to [26]. R1 = Ph, 3-MeC6H4, 3-MeOC6H4, 4-MeC6H4, 4-t-BuC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4, 3,4-F2C6H3, 4-CF3C6H4, 4-NCC6H4, 4-EtO2CC6H4, 4- C6H5-C6H4, 2-naphthyl, Me, Ph; R2 = H, 6-Me, and others; *—optically active center.
Scheme 8. Ir-catalyzed asymmetric hydrogenation of pyrrolo [1,2-a]pyrazinium salts, according to [26]. R1 = Ph, 3-MeC6H4, 3-MeOC6H4, 4-MeC6H4, 4-t-BuC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4, 3,4-F2C6H3, 4-CF3C6H4, 4-NCC6H4, 4-EtO2CC6H4, 4- C6H5-C6H4, 2-naphthyl, Me, Ph; R2 = H, 6-Me, and others; *—optically active center.
Molecules 30 03911 sch008
Scheme 9. Ir-catalyzed asymmetric hydrogenation of tosylamido-phenyl pyrazine, according to [29]. R = p-MeOC6H4, p-CF3C6H4, p-CO2MeC6H4, m-MeOC6H4, m-CF3C6H4, o-MeC6H4, cyclopentyl, n-hexyl; *—optically active center.
Scheme 9. Ir-catalyzed asymmetric hydrogenation of tosylamido-phenyl pyrazine, according to [29]. R = p-MeOC6H4, p-CF3C6H4, p-CO2MeC6H4, m-MeOC6H4, m-CF3C6H4, o-MeC6H4, cyclopentyl, n-hexyl; *—optically active center.
Molecules 30 03911 sch009
Scheme 10. Ir-catalyzed asymmetric hydrogenation of 2,5-diaryl pyrrolo [1,2-a][1,2,4]triazolo [5,1-c]pyrazines, according to [45]. R1 = Ph, OMe, MeO-C6H4, and others; R2 = Ph, CH3-C6H4, 3-CH3O-C6H4, 4-CH3O-C6H4, 3-F-C6H4, 4-Cl-C6H4, 4-OH-C6H4, i-Pr-Ph, and others; *—optically active center.
Scheme 10. Ir-catalyzed asymmetric hydrogenation of 2,5-diaryl pyrrolo [1,2-a][1,2,4]triazolo [5,1-c]pyrazines, according to [45]. R1 = Ph, OMe, MeO-C6H4, and others; R2 = Ph, CH3-C6H4, 3-CH3O-C6H4, 4-CH3O-C6H4, 3-F-C6H4, 4-Cl-C6H4, 4-OH-C6H4, i-Pr-Ph, and others; *—optically active center.
Molecules 30 03911 sch010
Scheme 11. Enantioselective nucleophilic dearomatization of quinazoline using an organocatalyst, according to [31]; *—optically active center.
Scheme 11. Enantioselective nucleophilic dearomatization of quinazoline using an organocatalyst, according to [31]; *—optically active center.
Molecules 30 03911 sch011
Scheme 12. ZrCl4-catalyzed nucleophilic dearomatization of 2-hydroxy-pyrimidines with phosphites, according to [37]. R1 = Ph, 3-Me-C6H4, 4-Me-C6H4, 3-Cl-C6H4, 4-Cl-C6H4, 3-MeO-C6H4, 2,4-F2C6H3, Me; R2 = Me, Ph, 3-Me-C6H4, 4-Me-C6H4, 3-Cl-C6H4, 4-Cl-C6H4; and R = Me, Et, i-Pr.
Scheme 12. ZrCl4-catalyzed nucleophilic dearomatization of 2-hydroxy-pyrimidines with phosphites, according to [37]. R1 = Ph, 3-Me-C6H4, 4-Me-C6H4, 3-Cl-C6H4, 4-Cl-C6H4, 3-MeO-C6H4, 2,4-F2C6H3, Me; R2 = Me, Ph, 3-Me-C6H4, 4-Me-C6H4, 3-Cl-C6H4, 4-Cl-C6H4; and R = Me, Et, i-Pr.
Molecules 30 03911 sch012
Scheme 13. LiHBEt3-catalyzed transition and metal-free hydrosilylation of a quinoxaline with 1,2,3,4-tetrahydroquinoxaline, according to [49].
Scheme 13. LiHBEt3-catalyzed transition and metal-free hydrosilylation of a quinoxaline with 1,2,3,4-tetrahydroquinoxaline, according to [49].
Molecules 30 03911 sch013
Scheme 14. Catalytic 1,2-regioselective dearomatization of quinoxaline via a hydroboration, according to [33].
Scheme 14. Catalytic 1,2-regioselective dearomatization of quinoxaline via a hydroboration, according to [33].
Molecules 30 03911 sch014
Scheme 15. (a) Birch-type photoreduction of phenazine; (b) mechanistic proposal, according to [55]; *—optically active center.
Scheme 15. (a) Birch-type photoreduction of phenazine; (b) mechanistic proposal, according to [55]; *—optically active center.
Molecules 30 03911 sch015
Scheme 16. Catalytic 1,2-regioselective dearomatization of N-heteroaromatics via hydroboration, according to [33].
Scheme 16. Catalytic 1,2-regioselective dearomatization of N-heteroaromatics via hydroboration, according to [33].
Molecules 30 03911 sch016
Scheme 17. Metal-free selective synthesis of pyridazines, according to [56]. R1 = aryl, heteroaryl; R2 − R3 = alkyl, cycloalkyl; and R4 = H, Ph; R5 = alkyl, aryl, heteroaryl, Ts.
Scheme 17. Metal-free selective synthesis of pyridazines, according to [56]. R1 = aryl, heteroaryl; R2 − R3 = alkyl, cycloalkyl; and R4 = H, Ph; R5 = alkyl, aryl, heteroaryl, Ts.
Molecules 30 03911 sch017
Scheme 18. Cu-catalyzed tandem reaction of 5-(2-bromoaryl)-1H-pyrazoles with carbonyl compounds and aqueous ammonia, according to [58]. R1 = Me, Ph, 4-Cl-C6H4, 4-Me-C6H4; R2 = H, Cl, OMe; and R3 = alkyl, aryl, heteroaryl.
Scheme 18. Cu-catalyzed tandem reaction of 5-(2-bromoaryl)-1H-pyrazoles with carbonyl compounds and aqueous ammonia, according to [58]. R1 = Me, Ph, 4-Cl-C6H4, 4-Me-C6H4; R2 = H, Cl, OMe; and R3 = alkyl, aryl, heteroaryl.
Molecules 30 03911 sch018
Scheme 19. (a) [2+2+2] Cycloaddition reaction of 1,3,5-triphenyl-1,3,5-triazinane with but-2-ynedioate; (b) plausible mechanism, according to [59].
Scheme 19. (a) [2+2+2] Cycloaddition reaction of 1,3,5-triphenyl-1,3,5-triazinane with but-2-ynedioate; (b) plausible mechanism, according to [59].
Molecules 30 03911 sch019
Scheme 20. (a) Catalyst-free synthesis of tetrahydropyrimidines via formal [3+3]-cycloaddition of imines with 1,3,5-hexahydro-1,3,5-triazines; (b) plausible mechanism, according to [60]. R = 4-MeO-C6H4; R1 = Ph, 4-Me-C6H4, 4-Br-C6H4; R2 = Me, Bu, Ph, 4-BrC6H4, 2,4-Cl2C6H4; and R3 = 4-MeO-C6H4.
Scheme 20. (a) Catalyst-free synthesis of tetrahydropyrimidines via formal [3+3]-cycloaddition of imines with 1,3,5-hexahydro-1,3,5-triazines; (b) plausible mechanism, according to [60]. R = 4-MeO-C6H4; R1 = Ph, 4-Me-C6H4, 4-Br-C6H4; R2 = Me, Bu, Ph, 4-BrC6H4, 2,4-Cl2C6H4; and R3 = 4-MeO-C6H4.
Molecules 30 03911 sch020
Scheme 21. [4+2] Cycloaddition of enaminones with 1,3,5-triazinanes, according to [61]. R = alkyl, aryl; R1 = Bn, Ph.
Scheme 21. [4+2] Cycloaddition of enaminones with 1,3,5-triazinanes, according to [61]. R = alkyl, aryl; R1 = Bn, Ph.
Molecules 30 03911 sch021
Scheme 22. (a) Sc-Catalyzed tandem cyclization of o-hydroxyphenyl enaminones with 1,3,5-triazinanes; (b) proposed mechanism, according to [62]. R = F, Cl, Br, Me, MeO; R1 = Bn, Ph, and others.
Scheme 22. (a) Sc-Catalyzed tandem cyclization of o-hydroxyphenyl enaminones with 1,3,5-triazinanes; (b) proposed mechanism, according to [62]. R = F, Cl, Br, Me, MeO; R1 = Bn, Ph, and others.
Molecules 30 03911 sch022
Scheme 23. (a) Rh-catalyzed [4+2] annulation of ester-tethered triazole and hexahydro-1,3,5-triazines; (b) proposed mechanism, according to [63]. R1 = Me-C6H4, Ph, CO2Me-C6H4, MeO-C6H4, X-C6H4 (X = Cl, Br, F), and others; R2 = Me, 3-Me-C6H4, 3-MeO-C6H4, 3-CF3-C6H4, and others; and R3 = 3-Me-C6H4, i-Pr, Me, and others.
Scheme 23. (a) Rh-catalyzed [4+2] annulation of ester-tethered triazole and hexahydro-1,3,5-triazines; (b) proposed mechanism, according to [63]. R1 = Me-C6H4, Ph, CO2Me-C6H4, MeO-C6H4, X-C6H4 (X = Cl, Br, F), and others; R2 = Me, 3-Me-C6H4, 3-MeO-C6H4, 3-CF3-C6H4, and others; and R3 = 3-Me-C6H4, i-Pr, Me, and others.
Molecules 30 03911 sch023
Scheme 24. Annulations of phosphoryl diazomethanes and 1,3,5-triazinanes, according to [64]. R1, R2 = Ar, Alkoxy; R3 = aryl, alkyl.
Scheme 24. Annulations of phosphoryl diazomethanes and 1,3,5-triazinanes, according to [64]. R1, R2 = Ar, Alkoxy; R3 = aryl, alkyl.
Molecules 30 03911 sch024
Scheme 25. Synthesis of dihydropyrimidine-2(1H)-thiones, according to [65]. R = H, 4-Me, 4-Cl, 4-F; R1 = H, 2,4-OMe.
Scheme 25. Synthesis of dihydropyrimidine-2(1H)-thiones, according to [65]. R = H, 4-Me, 4-Cl, 4-F; R1 = H, 2,4-OMe.
Molecules 30 03911 sch025
Scheme 26. (a) Three-component reaction of amines, 1,3,5-triazinanes, and alkyne esters for the construction of tetrahydropyrimidine derivatives; (b) proposed mechanism, according to [66]. R1 = Bn, cyclophentyl, cyclopropyl, and others; R2 = Ph; R3 = Me.
Scheme 26. (a) Three-component reaction of amines, 1,3,5-triazinanes, and alkyne esters for the construction of tetrahydropyrimidine derivatives; (b) proposed mechanism, according to [66]. R1 = Bn, cyclophentyl, cyclopropyl, and others; R2 = Ph; R3 = Me.
Molecules 30 03911 sch026aMolecules 30 03911 sch026b
Scheme 27. (a) Synthesis of chromeno [2,3-d]pyrimidin-5-one derivatives from 1,3,5-triazinanes; (b) proposed mechanism, according to [67]. R1 = H, Me, Cl, Br, F, and others; R2 = Me-C6H4.
Scheme 27. (a) Synthesis of chromeno [2,3-d]pyrimidin-5-one derivatives from 1,3,5-triazinanes; (b) proposed mechanism, according to [67]. R1 = H, Me, Cl, Br, F, and others; R2 = Me-C6H4.
Molecules 30 03911 sch027
Scheme 28. [4+2]-Cycloaddition of 1,3,5- triazinanes with aryl amides, according to [68]. R = Ph, Me-C6H4, X-C6H4 (X = F, Cl, Br), and others; R1 = H; R2 = H, Me; and R3 = Me-C6H4, F-Ph, NO2-Ph, and others.
Scheme 28. [4+2]-Cycloaddition of 1,3,5- triazinanes with aryl amides, according to [68]. R = Ph, Me-C6H4, X-C6H4 (X = F, Cl, Br), and others; R1 = H; R2 = H, Me; and R3 = Me-C6H4, F-Ph, NO2-Ph, and others.
Molecules 30 03911 sch028
Scheme 29. (a) Asymmetric [4+2]-cycloaddition of Cu−allenylidenes with hexahydro-1,3,5-triazines; (b) proposed mechanism, according to [69]. R1 = Me-C6H4, R2 = Bn, Me, Me-C6H4, X-C6H4 (X = Cl, Br, OMe), and others.
Scheme 29. (a) Asymmetric [4+2]-cycloaddition of Cu−allenylidenes with hexahydro-1,3,5-triazines; (b) proposed mechanism, according to [69]. R1 = Me-C6H4, R2 = Bn, Me, Me-C6H4, X-C6H4 (X = Cl, Br, OMe), and others.
Molecules 30 03911 sch029
Scheme 30. Synthesis of 1,2,3,4-tetrahydroquinazolines from α-azidocarboxylic acids and 2-(aminomethyl)aniline, according to [70]. R1 = H, Me, Ph; R2 = H, n-Bu, iPr, C6H4-CH2-, t-Bu, and others.
Scheme 30. Synthesis of 1,2,3,4-tetrahydroquinazolines from α-azidocarboxylic acids and 2-(aminomethyl)aniline, according to [70]. R1 = H, Me, Ph; R2 = H, n-Bu, iPr, C6H4-CH2-, t-Bu, and others.
Molecules 30 03911 sch030
Scheme 31. (a) Acetic acid promoted [2+2+1+1] cycloaddition of 1,3,5-triazinanes with active methylene; (b) proposed mechanism, according to [71]. R1 = Me, OEt, and others; R2 = Me, C6H4-C2H2, and others; and Ar = Ph, Me-C6H4, MeO-C6H4, X-C6H4 (X = Cl, F), and others.
Scheme 31. (a) Acetic acid promoted [2+2+1+1] cycloaddition of 1,3,5-triazinanes with active methylene; (b) proposed mechanism, according to [71]. R1 = Me, OEt, and others; R2 = Me, C6H4-C2H2, and others; and Ar = Ph, Me-C6H4, MeO-C6H4, X-C6H4 (X = Cl, F), and others.
Molecules 30 03911 sch031
Scheme 32. (a) Cyclization of indoline-derived azadienes with 1,3,5-triazinanes, according to [72,73]; (b) proposed mechanism, according to [72]; and (c) proposed mechanism, according to [73]. R = Me, H; R1 = H, Me, OMe, F, Cl, Br; R2 = Ph, Me-C6H4, and others; R3 = Ts, NO2-C6H4, and others; and R4 = Me, Ac.
Scheme 32. (a) Cyclization of indoline-derived azadienes with 1,3,5-triazinanes, according to [72,73]; (b) proposed mechanism, according to [72]; and (c) proposed mechanism, according to [73]. R = Me, H; R1 = H, Me, OMe, F, Cl, Br; R2 = Ph, Me-C6H4, and others; R3 = Ts, NO2-C6H4, and others; and R4 = Me, Ac.
Molecules 30 03911 sch032aMolecules 30 03911 sch032b
Scheme 33. One-pot synthesis of thieno [3,2-e]pyrrolo [1,2-a]pyrimidine derivatives, according to [74]. R1 = alkyl, cycloalkyl; R2 alkyl, cycloalkyl, Ph; R3 = t-Bu, aryl, heteroaryl; and R4 = COOEt, CONH2, CN.
Scheme 33. One-pot synthesis of thieno [3,2-e]pyrrolo [1,2-a]pyrimidine derivatives, according to [74]. R1 = alkyl, cycloalkyl; R2 alkyl, cycloalkyl, Ph; R3 = t-Bu, aryl, heteroaryl; and R4 = COOEt, CONH2, CN.
Molecules 30 03911 sch033
Scheme 34. One-pot synthesis of pyrrolo [2,3-d]pyrimidine derivatives, according to [75]. Ar = Ph, 4-Me-C6H4, 4-Cl-C6H4, 4-NO2-C6H4; R = H, Me; Y = O, S.
Scheme 34. One-pot synthesis of pyrrolo [2,3-d]pyrimidine derivatives, according to [75]. Ar = Ph, 4-Me-C6H4, 4-Cl-C6H4, 4-NO2-C6H4; R = H, Me; Y = O, S.
Molecules 30 03911 sch034
Scheme 35. Enantioselective dearomative [3+2] annulation reaction of quinoxaline and 2-butyne, according to [76].
Scheme 35. Enantioselective dearomative [3+2] annulation reaction of quinoxaline and 2-butyne, according to [76].
Molecules 30 03911 sch035
Scheme 36. Ru-catalyzed annulative transfer hydrogenation strategy based on N-heteroaryl diamines and vicinal diols, according to [77]. R1 = H, Me, and others; R2 = Me, Ph, H, and others.
Scheme 36. Ru-catalyzed annulative transfer hydrogenation strategy based on N-heteroaryl diamines and vicinal diols, according to [77]. R1 = H, Me, and others; R2 = Me, Ph, H, and others.
Molecules 30 03911 sch036
Scheme 37. (a) Alkoxide-promoted selective hydroboration of N-heteroarenes; (b) proposed catalytic cycle, according to [78]. R = H, Me, Et.
Scheme 37. (a) Alkoxide-promoted selective hydroboration of N-heteroarenes; (b) proposed catalytic cycle, according to [78]. R = H, Me, Et.
Molecules 30 03911 sch037aMolecules 30 03911 sch037b
Scheme 38. Enantioselective catalytic dearomatization of pyrazine, according to [35]. R1 = Ph, MeO-C6H4, and others; R2 = H, OH, Ac, and others. ‘Quench’ is a procedure that stops (or quenches) the reaction. In the standard version, this is achieved by adding 2.0 mL of methanol to the reaction solution using a syringe and stirring for 15 min.
Scheme 38. Enantioselective catalytic dearomatization of pyrazine, according to [35]. R1 = Ph, MeO-C6H4, and others; R2 = H, OH, Ac, and others. ‘Quench’ is a procedure that stops (or quenches) the reaction. In the standard version, this is achieved by adding 2.0 mL of methanol to the reaction solution using a syringe and stirring for 15 min.
Molecules 30 03911 sch038
Scheme 39. One-pot synthesis of pyrrolo[1,2-a]pyrazines, according to [79]. R = Ph, 4-MeC6H4, 4-ClC6H4, 4-NO2C6H4.
Scheme 39. One-pot synthesis of pyrrolo[1,2-a]pyrazines, according to [79]. R = Ph, 4-MeC6H4, 4-ClC6H4, 4-NO2C6H4.
Molecules 30 03911 sch039
Scheme 40. Synthesis of 3,4-dihydrobenzo[d][1,2,3]triazine derivatives, according to [80]. R1 = alkyl, cycloalkyl, Bn, 4-Me-Bn, 3,5-F-Bn; R2 = Me, Ph, iBu.
Scheme 40. Synthesis of 3,4-dihydrobenzo[d][1,2,3]triazine derivatives, according to [80]. R1 = alkyl, cycloalkyl, Bn, 4-Me-Bn, 3,5-F-Bn; R2 = Me, Ph, iBu.
Molecules 30 03911 sch040
Scheme 41. Synthesis of substituted 12-nitrosopyrido [3′,2′:4,5]pyrrolo [1,2-c][1,2,3] benzotriazines, according to [81]. R1 = H, Cl, Me, OMe; R2 = H, Cl, OMe; and X = Br, NO2.
Scheme 41. Synthesis of substituted 12-nitrosopyrido [3′,2′:4,5]pyrrolo [1,2-c][1,2,3] benzotriazines, according to [81]. R1 = H, Cl, Me, OMe; R2 = H, Cl, OMe; and X = Br, NO2.
Molecules 30 03911 sch041
Scheme 42. (a) C−H/N−H bond functionalization of 1-phenylpyrazolidinones with oxadiazolones; (b) plausible mechanism, according to [83]. R1 = H, Me, Et, OMe, OBn, F, Cl, Br, CN, CF3, and others; R2 = H, Me; and R3 = H, Me; *—optically active center.
Scheme 42. (a) C−H/N−H bond functionalization of 1-phenylpyrazolidinones with oxadiazolones; (b) plausible mechanism, according to [83]. R1 = H, Me, Et, OMe, OBn, F, Cl, Br, CN, CF3, and others; R2 = H, Me; and R3 = H, Me; *—optically active center.
Molecules 30 03911 sch042
Scheme 43. Dearomative [4+2] annulation of electron-poor N-heteroarenes with azoalkenes, according to [84]. R1 = H, Br, F, CN; R2 = H, Ph, OCH3, O-t-Bu, O-Bn; and R3 =Cl, H.
Scheme 43. Dearomative [4+2] annulation of electron-poor N-heteroarenes with azoalkenes, according to [84]. R1 = H, Br, F, CN; R2 = H, Ph, OCH3, O-t-Bu, O-Bn; and R3 =Cl, H.
Molecules 30 03911 sch043
Scheme 44. One-pot synthesis of novel 4-aza-9-deaza-guanine isosteres, according to [85]. R1 = H, 4-OMe, 2,4-(OMe)2, 3,4,5-(OMe)3; R2 = Ph, 4-Cl-C6H5, 4-MeO-C6H5, 2,4-(OMe)2-C6H5, 4-Br-C6H5, and others; and R3 = Ph, i-Pr, and others.
Scheme 44. One-pot synthesis of novel 4-aza-9-deaza-guanine isosteres, according to [85]. R1 = H, 4-OMe, 2,4-(OMe)2, 3,4,5-(OMe)3; R2 = Ph, 4-Cl-C6H5, 4-MeO-C6H5, 2,4-(OMe)2-C6H5, 4-Br-C6H5, and others; and R3 = Ph, i-Pr, and others.
Molecules 30 03911 sch044
Scheme 45. (a) Metal-free [2+1+3] cycloaddition of trifluoroacetaldehyde N-sulfonylhydrazones with hexahydro-1,3,5-triazines; (b) plausible mechanism, according to [86]. R1, R2 = Aryl, alkyl.
Scheme 45. (a) Metal-free [2+1+3] cycloaddition of trifluoroacetaldehyde N-sulfonylhydrazones with hexahydro-1,3,5-triazines; (b) plausible mechanism, according to [86]. R1, R2 = Aryl, alkyl.
Molecules 30 03911 sch045aMolecules 30 03911 sch045b
Scheme 46. Synthesis of 2,3,6-trioxo-8-aryl-1,3,4,6-tetrahydro-]2H[pyrido]1,2-b] [1,2,4[triazin-7,9-dicarbonitryls, according to [87]. R = H, Me, OMe, Cl, NO2, N(CH3)2, F, Br, OH.
Scheme 46. Synthesis of 2,3,6-trioxo-8-aryl-1,3,4,6-tetrahydro-]2H[pyrido]1,2-b] [1,2,4[triazin-7,9-dicarbonitryls, according to [87]. R = H, Me, OMe, Cl, NO2, N(CH3)2, F, Br, OH.
Molecules 30 03911 sch046
Scheme 47. Synthesis of pyrrolo [1,2-a][1,3,5]triazine-2,4(1H,3H)-diones, according to [88].
Scheme 47. Synthesis of pyrrolo [1,2-a][1,3,5]triazine-2,4(1H,3H)-diones, according to [88].
Molecules 30 03911 sch047
Scheme 48. Synthesis of pyrrolo[1,3,5]triazine, according to [89].
Scheme 48. Synthesis of pyrrolo[1,3,5]triazine, according to [89].
Molecules 30 03911 sch048
Scheme 49. (a) Sm-mediated synthesis of di-tert-butyl-bis-1,3,5-triazinane; (b) gram-scale synthesis of bis-1,3,5-triazinanes 158, according to [90].
Scheme 49. (a) Sm-mediated synthesis of di-tert-butyl-bis-1,3,5-triazinane; (b) gram-scale synthesis of bis-1,3,5-triazinanes 158, according to [90].
Molecules 30 03911 sch049
Scheme 50. Synthesis of 2,6-disubstituted 2,3a,4a,6,7a,8a-hexaaza-perhydrocyclopenta[def]fluorine-4-thioxo-8-ones, according to [19].
Scheme 50. Synthesis of 2,6-disubstituted 2,3a,4a,6,7a,8a-hexaaza-perhydrocyclopenta[def]fluorine-4-thioxo-8-ones, according to [19].
Molecules 30 03911 sch050
Scheme 51. Intermolecular heterocyclization of N,N-bis(methoxymethyl)-N-alkylamines with 2,6(7)-dimethyl-1,4,5,8-tetraazadecalins, according to [95]. R = n-Pr (81% total yield), n-Bu (83% total yield), i-Pr (77% yield), and t-Bu (79% yield).
Scheme 51. Intermolecular heterocyclization of N,N-bis(methoxymethyl)-N-alkylamines with 2,6(7)-dimethyl-1,4,5,8-tetraazadecalins, according to [95]. R = n-Pr (81% total yield), n-Bu (83% total yield), i-Pr (77% yield), and t-Bu (79% yield).
Molecules 30 03911 sch051
Scheme 52. Yb-catalyzed synthesis of 2,7-diaryl(hetaryl)-4,9-dimethyl-perhydro-2,3a,5a,7,8a,10a-hexaazapyrenes, according to [96]. R = 2-HOC6H4; 4-HOC6H4; 4-HOC(O)C6H4; 3-HO-4-HOC(O)C6H3; 5-methyl-1,2-oxazol-3-yl; 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl; and pyridine-2-yl.
Scheme 52. Yb-catalyzed synthesis of 2,7-diaryl(hetaryl)-4,9-dimethyl-perhydro-2,3a,5a,7,8a,10a-hexaazapyrenes, according to [96]. R = 2-HOC6H4; 4-HOC6H4; 4-HOC(O)C6H4; 3-HO-4-HOC(O)C6H3; 5-methyl-1,2-oxazol-3-yl; 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl; and pyridine-2-yl.
Molecules 30 03911 sch052
Scheme 53. Cu-catalyzed synthesis of cyclic tetrazene, according to [98].
Scheme 53. Cu-catalyzed synthesis of cyclic tetrazene, according to [98].
Molecules 30 03911 sch053
Scheme 54. Synthesis of pyrrolo [2,1-d][1,2,3,5]tetrazine-4(3H)-ones, according to [99]. R = CN, CONH2, CO2Et; R1 = Me, Ph; R2 = Me, Ph; and R3 = Me, cyclohexyl, Ph, heteroaryl.
Scheme 54. Synthesis of pyrrolo [2,1-d][1,2,3,5]tetrazine-4(3H)-ones, according to [99]. R = CN, CONH2, CO2Et; R1 = Me, Ph; R2 = Me, Ph; and R3 = Me, cyclohexyl, Ph, heteroaryl.
Molecules 30 03911 sch054
Scheme 55. Synthesis of pyrrolo [1,2-b][1,2,4,5]tetrazine derivatives, according to [100,101].
Scheme 55. Synthesis of pyrrolo [1,2-b][1,2,4,5]tetrazine derivatives, according to [100,101].
Molecules 30 03911 sch055
Scheme 56. Dimerization of N-aminopyridinium salts, according to [102,103]. R1 = COR’; R’ = OEt, ClC6H4; R2 = H, Me; R3 = H, Me; R4 = H, Me, OMe; R5 = H, Me, OMe, Cl; and X = OMeS.
Scheme 56. Dimerization of N-aminopyridinium salts, according to [102,103]. R1 = COR’; R’ = OEt, ClC6H4; R2 = H, Me; R3 = H, Me; R4 = H, Me, OMe; R5 = H, Me, OMe, Cl; and X = OMeS.
Molecules 30 03911 sch056
Scheme 57. Synthesis of 2,3,4a,6,7,8a,9,10-octaaza-4,8-dioxo-3,4,4a,7,8,8a,9,9a,10,10a-decahydro-anthracene, according to [104].
Scheme 57. Synthesis of 2,3,4a,6,7,8a,9,10-octaaza-4,8-dioxo-3,4,4a,7,8,8a,9,9a,10,10a-decahydro-anthracene, according to [104].
Molecules 30 03911 sch057
Scheme 58. Synthesis of tetrazo [1,2-b]indazoles, according to [105].
Scheme 58. Synthesis of tetrazo [1,2-b]indazoles, according to [105].
Molecules 30 03911 sch058
Scheme 59. Dearomative [4+2] cycloaddition between 1,2-dihydro-1,2,4,5-tetrazine-3,6-diones and benzenes, naphthalenes, or N-heteroaromatic compounds, according to [106]. R = Me, Bn, 2,4-(CF3)2-C6H3; 189 = benzenes, naphthalenes, N-heteroarenes.
Scheme 59. Dearomative [4+2] cycloaddition between 1,2-dihydro-1,2,4,5-tetrazine-3,6-diones and benzenes, naphthalenes, or N-heteroaromatic compounds, according to [106]. R = Me, Bn, 2,4-(CF3)2-C6H3; 189 = benzenes, naphthalenes, N-heteroarenes.
Molecules 30 03911 sch059
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Titova, Y.Y.; Gyrgenova, E.A.; Ivanov, A.V. Efficient Approaches to the Design of Six-Membered Polyazocyclic Compounds—Part 2: Nonaromatic Frameworks. Molecules 2025, 30, 3911. https://doi.org/10.3390/molecules30193911

AMA Style

Titova YY, Gyrgenova EA, Ivanov AV. Efficient Approaches to the Design of Six-Membered Polyazocyclic Compounds—Part 2: Nonaromatic Frameworks. Molecules. 2025; 30(19):3911. https://doi.org/10.3390/molecules30193911

Chicago/Turabian Style

Titova, Yuliya Yu., Elena A. Gyrgenova, and Andrey V. Ivanov. 2025. "Efficient Approaches to the Design of Six-Membered Polyazocyclic Compounds—Part 2: Nonaromatic Frameworks" Molecules 30, no. 19: 3911. https://doi.org/10.3390/molecules30193911

APA Style

Titova, Y. Y., Gyrgenova, E. A., & Ivanov, A. V. (2025). Efficient Approaches to the Design of Six-Membered Polyazocyclic Compounds—Part 2: Nonaromatic Frameworks. Molecules, 30(19), 3911. https://doi.org/10.3390/molecules30193911

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop